JPH0314035B2 - - Google Patents

Info

Publication number
JPH0314035B2
JPH0314035B2 JP57047829A JP4782982A JPH0314035B2 JP H0314035 B2 JPH0314035 B2 JP H0314035B2 JP 57047829 A JP57047829 A JP 57047829A JP 4782982 A JP4782982 A JP 4782982A JP H0314035 B2 JPH0314035 B2 JP H0314035B2
Authority
JP
Japan
Prior art keywords
value
added
compound
nax
nitrobenzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57047829A
Other languages
Japanese (ja)
Other versions
JPS58164591A (en
Inventor
Hamao Umezawa
Masaji Oono
Hiroshi Ishihama
Yoshinori Kyotani
Yoshio Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Priority to JP57047829A priority Critical patent/JPS58164591A/en
Priority to US06/477,369 priority patent/US4511509A/en
Priority to EP83301648A priority patent/EP0091239A1/en
Publication of JPS58164591A publication Critical patent/JPS58164591A/en
Publication of JPH0314035B2 publication Critical patent/JPH0314035B2/ja
Granted legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は新規なβ−ラクタム系化合物、更に詳
細には、一般式(1) (式中、R1及びR2は同一又は異なつてメチル基
又はヒドロキシメチル基を、R3はピリジル基又
は低級アルキル基で置換されていてもよいピリミ
ジニル基を、R4は水素原子又は置換基を有して
いてもよいベンジル基を示す)で表わされる化合
物及びその塩に関する。 近年、天然より発見されたチエナマイシン(特
開昭51−73191号)がその構造、強い抗菌力、β
−ラクタマーゼ阻害作用を有することなどから、
注目され、更にその後、この系統に属する化合物
が多数報告されている。しかしながら、これらは
何れも不安定な化合物であり、醗酵による生産性
が低いため、実用に供されていない。 そこで、本発明者は、当該系統の化合物を合成
によつて製造せんと種々研究を行つた結果、前記
(1)式で表わされる新規なβ−ラクタム系化合物を
合成することに成功し、しかもこの化合物が抗生
物質として有用であることを見出し、本発明を完
成した。 本発明によれば、式(1)の化合物は、次の反応式
に従つて製造することができる。 (但し、式中の
The present invention relates to a novel β-lactam compound, more specifically, a compound represented by the general formula (1). (In the formula, R 1 and R 2 are the same or different and represent a methyl group or a hydroxymethyl group, R 3 is a pyridyl group or a pyrimidinyl group which may be substituted with a lower alkyl group, and R 4 is a hydrogen atom or a substituent. (optionally having a benzyl group) and salts thereof. Thienamycin (Japanese Unexamined Patent Publication No. 73191/1989), which was discovered in nature in recent years, has a strong structure, strong antibacterial activity, and
-Because it has lactamase inhibitory effect, etc.
It attracted attention, and subsequently many compounds belonging to this family have been reported. However, these are all unstable compounds and have low productivity through fermentation, so they are not put to practical use. Therefore, the present inventor conducted various researches in an attempt to synthesize compounds of this type, and as a result, the above-mentioned
The present invention was completed by successfully synthesizing a novel β-lactam compound represented by formula (1) and discovering that this compound is useful as an antibiotic. According to the present invention, the compound of formula (1) can be produced according to the following reaction formula. (However, in the ceremony

【式】はt−ブチルジメチ ルシリル基を、R4′は置換基を有していてもよい
ベンジル基を、R5は低級アルキル基を示し、他
の記号は前記の意味を有する) 原料化合物()は例えば大野らの方法〔J.
Am.Chem.Soc.103 2406(1981)〕に従い、安価
な3−ケトグルタール酸のジアルキルエステルよ
り容易に製造することができる。 次に本発明の前記方法の各反応につき詳述す
る。 ()→() 化合物()に1〜3当量のt−ブチルジメチ
ルシリルハロゲナイド、好ましくはクロライドを
作用させることによつて化合物()が得られ
る。反応は溶媒中で塩基の存在下に行うのが好ま
しい。溶媒としてはジメチルホルムアミド、テト
ラヒドロフラン等を、塩基としてはトリエチルア
ミンのような三級アミン、n−ブチルリチウム等
を使用することができる。反応は−30〜+20℃で
数分乃至数時間で終了する。 ()→() 化合物()を還元すると化合物()が得ら
れる。還元は水素化アルミニウム金属化合物例え
ば、水素化リチウムアルミニウム;水素化ホウ素
金属化合物、例えば水素化ホウ素ナトリウム、水
素化ホウ素リチウム等の還元剤を用いる方法が好
ましい。反応及び分離・精製は通常の方法を利用
することができる。 ()→() 化合物()にt−ブチルジメチルシリルハロ
ゲナイドを作用させることによつて化合物()
が得られる。反応は溶媒中で塩基の存在下に行う
のが好ましい。溶媒としては、ジメチルホルムア
ミド、ピリジン等を、塩基としてはトリエチルア
ミンのような三級アミン、イミダゾール、ピリジ
ン等を利用することができる。 ()→() 化合物()の第3位を活性化させたのち、ハ
ロゲン化トリアルキルシランを作用させて、3−
トリアルキルシリル化合物としたのち、式
[Formula] represents a t-butyldimethylsilyl group, R 4 ' represents a benzyl group which may have a substituent, R 5 represents a lower alkyl group, and other symbols have the above meanings) Raw material compound () is, for example, the method of Ohno et al. [J.
Am.Chem.Soc. 103 2406 (1981)], it can be easily produced from an inexpensive dialkyl ester of 3-ketoglutaric acid. Next, each reaction in the method of the present invention will be explained in detail. ()→() Compound () is obtained by reacting compound () with 1 to 3 equivalents of t-butyldimethylsilylhalogenide, preferably chloride. Preferably, the reaction is carried out in a solvent in the presence of a base. Dimethylformamide, tetrahydrofuran, etc. can be used as the solvent, and tertiary amines such as triethylamine, n-butyllithium, etc. can be used as the base. The reaction is completed in several minutes to several hours at -30 to +20°C. ()→() Compound () is obtained by reducing compound (). The reduction is preferably carried out using a reducing agent such as an aluminum hydride metal compound, such as lithium aluminum hydride; or a borohydride metal compound, such as sodium borohydride or lithium borohydride. Conventional methods can be used for reaction, separation and purification. ()→() By reacting compound () with t-butyldimethylsilylhalogenide, compound ()
is obtained. Preferably, the reaction is carried out in a solvent in the presence of a base. As the solvent, dimethylformamide, pyridine, etc. can be used, and as the base, tertiary amine such as triethylamine, imidazole, pyridine, etc. can be used. ()→() After activating the 3rd position of compound (), halogenated trialkylsilane is applied to form 3-
After making it into a trialkylsilyl compound, the formula

【式】(式中、R′1及びR′2は同 一又は異なつてメチル基又は保護されたヒドロキ
シメチル基を示す)で表わされる化合物を作用さ
せることによつて化合物()が得られる。化合
物()の3位を活性化させるためには、例え
ば、化合物()とリチウムジイソプロピルアミ
ドを溶媒、例えばテトラヒドロフラン中で低温で
反応させる方法を利用できる。活性化された化合
物()とシリル化合物例えばトリメチルシリル
クロライドとの反応は溶媒中、低温例えば−80℃
前後で行われる。3−トリアルキルシリル化合物
に化合物(XII)を作用させるときも、前記と同様
に低温下で反応させることが好ましい。 ()→() 化合物()を加水分解すると化合物()が
得られる。この加水分解は通常の加水分解方法を
適用することができるが、酸加水分解を利用する
ことが好ましい。特に好ましい例としては、塩酸
−メタノール−水系で0℃付近で1〜3時間反応
させる方法が挙げられる。 ()→() 化合物()を酸化すると化合物()が得ら
れる。酸化はクロム酸、ピリジニウムジクロメー
ト等の酸化剤を作用させる方法が好ましい。例え
ば、酸化剤としてクロム酸を用いる場合には、ピ
リジン等の溶媒中で化合物()と4〜10倍量の
クロム酸を10〜50℃で1〜30時間反応させること
によつて目的物が生成する。 ()→() 化合物()の活性誘導体にマロン酸モノベン
ジルエステルの活性誘導体を作用させると化合物
()が得られる。化合物()の活性誘導体と
しては通常のペプチド合成に用いられるものを利
用できるが、イミダゾライドを用いることが特に
好ましい。マロン酸モノエステルの活性誘導体と
しては中性マグネシウム塩の利用が特に好まし
い。これらを用いる場合は、化合物()と、例
えば1,1′−カルボニルジイミダゾールとをテト
ラヒドロフラン、ジメチルホルムアミド、ジオキ
サン等の溶媒中で反応させたのち、例えば、マロ
ン酸のモノ−p−ニトロベンジルエステルのマグ
ネシウム塩を加えて−5〜30℃で1〜30時間反応
させることにより化合物()が得られる。 ()→() 化合物()をジアゾ化すると化合物()が
得られる。ジアゾ化試薬としては、2−ナフチル
スルホニルアジド、p−トルエンスルホニルアジ
ド、メタンスルホニルアジド、p−カルボキシベ
ンゼンスルホニルアジドなどを使用することがで
きる。反応は溶媒中塩基の存在下に行うことが好
ましく、溶媒としては、アセトニトリル、塩化メ
チレン、テトラヒドロフラン等が、塩基として
は、トリエチルアミン、ジエチルアミン、ピリジ
ン等を用いることができる。反応は−5〜30℃で
10分〜1.0時間で進行する。 ()→(XI) 化合物()を環化して化合物(XI)を得るに
は、溶媒中で触媒の存在下に40〜100℃に加熱す
る。溶媒としてはベンゼン、トルエン等を、触媒
としてはロジウムアセタート、パラジウムアセタ
ート、硫酸銅、銅粉等を用いることができる。 (XI)→()′ 化合物(XI)の3位をリン酸エステル化もしく
はスルホニルエステル化して2,3位間に二重結
合を導入したのち、HSR3()を作用させる
と化合物()′が得られる。リン酸エステルと
してはジフエニルリン酸エステル等が、スルホニ
ルエステルとしては、p−トルエンスルホニルエ
ステル、トリフロロメタンスルホニルエステル等
が挙げられる。このエステル化は、化合物(XI)
と、前記エステルに対応するハロゲン化物、例え
ば塩化物を、溶媒中で塩基の存在下に反応させる
ことによつて達成される。溶媒としてはアセトニ
トリル、塩化メチレン、ジメチルホルムアミド、
テトラヒドロフラン等を、触媒としてはジイソプ
ロピルエチルアミン、トリエチルアミン、4−ジ
メチルアミノピリジン等を用いることができる。 こうして得られるエステルに化合物()を
作用させるときは、前記のような溶媒中で塩基の
存在下に−50〜+30℃で1〜30時間反応させるこ
とが好ましい。このとき用いられる塩基としては
トリエチルアミン、ジイソプロピルエチルアミ
ン、炭酸ナトリウム、炭酸水素ナトリウム、炭酸
カリウム等が挙げられる。 ()′→() R4が水素原子である化合物()は化合物
()′を加水分解又は加水素分解反応することに
よつて得られるが、加水素分解反応特に接触還元
方法を利用することが特に好ましい。接触還元に
用いられる好ましい触媒としてはパラジウム−炭
素、パラジウム黒、酸化白金、ラネ−ニツケル等
が挙げられる。前記式中、R1もしくはR2がヒド
ロキシメチル基である化合物を製造する際には、
前記の工程(→)に於いて化合物(XII)と
してR1もしくはR2が保護されたヒドロキシメチ
ル基の化合物を用いて反応させ、次いで当該保護
基を脱離して目的の化合物()を得ることもで
きるが、R1=R2=メチル基である化合物(XII)
を用いてR1=R2=メチル基である化合物()
を製造したのち、R1又はR2の一方をヒドロキシ
化する方法を採用することもできる。このヒドロ
キシ化は、例えば二酸化セレンを用いる酸化に引
き継ぎ水素化ホウ素ナトリウムのような還元剤を
用いる還元によつて達成できる。 尚、R1及び/又はR2がヒドロキシメチル基で
ある化合物を製造する際には、この工程以下の反
応を行うとき水酸基を保護しておくことが好まし
く、最終工程(′→)でカルボン酸のエス
テルを脱離する際に同時に脱離することが好まし
い。この保護基として特に好ましいものは置換基
を有し得るベンジルオキシカルボニル基である。 上記各反応によつて得られる化合物を反応液よ
り単離精製する方法としては、通常の方法を利用
できるが、ゲル過法、カラムクロマトグラフイ
ー、逆相カラムクロマトグラフイー、凍結乾燥方
法等を単独又は組み合せて利用するのが好まし
い。 また、式()の化合物は必要に応じ、更にア
ルカリ塩、例えばナトリウム、カリウム、リチウ
ム等のアルカリ金属塩;カルシウム、マグネシウ
ム等のアルカリ土類金属塩、第4級アンモニウム
塩とすることができる。 このようにして得られる本発明化合物()の
代表的なものの抗菌活性を示せば第1表のとおり
である。 試験化合物:
The compound () can be obtained by reacting with a compound represented by the formula: (wherein R' 1 and R' 2 are the same or different and represent a methyl group or a protected hydroxymethyl group). In order to activate the 3-position of the compound (), for example, a method of reacting the compound () with lithium diisopropylamide in a solvent such as tetrahydrofuran at a low temperature can be used. The reaction between the activated compound () and a silyl compound such as trimethylsilyl chloride is carried out in a solvent at a low temperature, e.g. -80°C.
It takes place before and after. When the 3-trialkylsilyl compound is reacted with the compound (XII), it is preferable to carry out the reaction at a low temperature in the same manner as above. () → () Compound () is obtained by hydrolyzing compound (). For this hydrolysis, a conventional hydrolysis method can be applied, but it is preferable to use acid hydrolysis. A particularly preferred example is a method of reacting in a hydrochloric acid-methanol-water system at around 0° C. for 1 to 3 hours. ()→() Oxidation of compound () yields compound (). The oxidation is preferably carried out using an oxidizing agent such as chromic acid or pyridinium dichromate. For example, when using chromic acid as an oxidizing agent, the desired product can be obtained by reacting the compound () with 4 to 10 times the amount of chromic acid at 10 to 50°C for 1 to 30 hours in a solvent such as pyridine. generate. () → () Compound () is obtained by reacting an active derivative of malonic acid monobenzyl ester with an active derivative of compound (). As the active derivative of compound (), those used in ordinary peptide synthesis can be used, but it is particularly preferable to use imidazolide. Particularly preferred is the use of neutral magnesium salts as active derivatives of malonic acid monoesters. When using these, the compound () and, for example, 1,1'-carbonyldiimidazole are reacted in a solvent such as tetrahydrofuran, dimethylformamide, dioxane, etc., and then, for example, mono-p-nitrobenzyl ester of malonic acid is reacted. Compound () is obtained by adding magnesium salt of and reacting at -5 to 30°C for 1 to 30 hours. () → () Compound () is obtained by diazotizing compound (). As the diazotization reagent, 2-naphthylsulfonyl azide, p-toluenesulfonyl azide, methanesulfonyl azide, p-carboxybenzenesulfonyl azide, etc. can be used. The reaction is preferably carried out in the presence of a base in a solvent, and the solvent may be acetonitrile, methylene chloride, tetrahydrofuran, etc., and the base may be triethylamine, diethylamine, pyridine, etc. Reaction at -5~30℃
Progresses in 10 minutes to 1.0 hours. ()→(XI) Compound () is cyclized to obtain compound (XI) by heating to 40-100°C in a solvent in the presence of a catalyst. Benzene, toluene, etc. can be used as a solvent, and rhodium acetate, palladium acetate, copper sulfate, copper powder, etc. can be used as a catalyst. (XI)→()′ After phosphoric acid esterification or sulfonyl esterification of the 3rd position of compound (XI) to introduce a double bond between the 2nd and 3rd positions, when HSR 3 () is applied, the compound ()′ is obtained. Examples of the phosphoric acid ester include diphenyl phosphoric ester, and examples of the sulfonyl ester include p-toluenesulfonyl ester and trifluoromethanesulfonyl ester. This esterification results in compound (XI)
and a halide corresponding to the ester, such as a chloride, in a solvent in the presence of a base. As a solvent, acetonitrile, methylene chloride, dimethylformamide,
Tetrahydrofuran and the like can be used, and diisopropylethylamine, triethylamine, 4-dimethylaminopyridine and the like can be used as the catalyst. When the compound () is reacted with the ester thus obtained, it is preferable to react in the above-mentioned solvent at -50 to +30°C for 1 to 30 hours in the presence of a base. Examples of the base used at this time include triethylamine, diisopropylethylamine, sodium carbonate, sodium hydrogencarbonate, potassium carbonate, and the like. ()′→() Compound () in which R 4 is a hydrogen atom can be obtained by hydrolysis or hydrogenolysis reaction of compound ()′, but it is difficult to use hydrolysis reaction, especially catalytic reduction method. is particularly preferred. Preferred catalysts used in the catalytic reduction include palladium-carbon, palladium black, platinum oxide, Raney-nickel, and the like. When producing a compound in which R 1 or R 2 is a hydroxymethyl group,
In the above step (→), react with a compound in which R 1 or R 2 is a protected hydroxymethyl group as compound (XII), and then remove the protecting group to obtain the target compound (). Compound (XII) where R 1 = R 2 = methyl group is also possible.
Compounds where R 1 = R 2 = methyl group () using
It is also possible to adopt a method of producing R 1 or R 2 and then hydroxylating either R 1 or R 2 . This hydroxylation can be achieved, for example, by oxidation with selenium dioxide followed by reduction with a reducing agent such as sodium borohydride. In addition, when producing a compound in which R 1 and/or R 2 are hydroxymethyl groups, it is preferable to protect the hydroxyl group during the reactions following this step, and in the final step ('→), the carboxylic acid group is It is preferable to eliminate the ester at the same time as the ester. A particularly preferred protecting group is a benzyloxycarbonyl group which may have a substituent. Conventional methods can be used to isolate and purify the compounds obtained by each of the above reactions from the reaction solution, but gel filtration, column chromatography, reversed-phase column chromatography, freeze-drying, etc. It is preferable to use them alone or in combination. Further, the compound of formula () can be further converted into an alkali salt, for example, an alkali metal salt such as sodium, potassium, or lithium; an alkaline earth metal salt such as calcium or magnesium; or a quaternary ammonium salt, if necessary. Table 1 shows the antibacterial activity of typical compounds of the present invention () obtained in this manner. Test compound:

【表】【table】

【表】【table】

【表】【table】

【表】 実施例 1 (5R)−p−ニトロベンジル6−イソプロピリ
デン−1−アザビシクロ〔3・2・0〕ヘプタン
−3,7−ジオン−2−カルボキシレートの製造 (a) (4S)−1−(t−ブチルジメチルシリル)−
4−(メトキシカルボニルメチル)−アゼチジン−
2−オンの製造 (4S)−4−(メトキシカルボニルメチル)−ア
ゼチジン−2−オン(J.A.C.S.103 2405
(1981)記載の方法で製造)2.0g及びトリエチル
アミン2.56mlをジメチルホルムアミド30mlに溶解
し、0℃に冷却して、撹拌下にt−ブチルジメチ
ルクロルシラン2.74gを加え、更に50分撹拌し
た。反応後ジメチルホルムアミドを留去し、残渣
を塩化メチレンに溶解して水洗及び乾燥したのち
濃縮した。残渣をシリカゲルカラムクロマトグラ
フイー〔溶媒:n−ヘキサン−酢酸エチル(5:
1)〕で精製すると、無色結晶の目的物3.47g
(収率96.8%)が得られた。 比旋光度:〔α〕25 D−80゜(c1.0、THF) IR値:νCHCl3 nax cm-1 1743、1735 PMR値:δCDCl3 ppm 0.20(3H,s)、0.23(3H,s)、 0.93(9H,s)、2.47(1H,dd,J=16Hz,
10Hz)、 2.76(1H,dd,J=16Hz,3Hz)、2.85(1H,
dd, J=15Hz,5Hz)、3.28(1H,dd,J=
15Hz,6Hz)、 3.68(3H,s)、3.88(1H,m) (b) (4R)−1−(t−ブチルジメチルシリル)−
4−(2−ヒドロキシエチル)−アゼチジン−2−
オンの製造 水素化アルミニウムリチウム270mgを無水エー
テル70mlに懸濁させ、窒素雰囲気下−20℃に冷
却、撹拌し、実施例1(a)で得られたエステル体
1.42gの無水エーテル70ml溶液を滴下して−20℃
で10分間撹拌した。反応液に2N塩酸を加えて過
剰の試薬を分解したのち、エーテルで抽出した。
抽出液を水洗及び乾燥したのち濃縮すると、無色
油状物として目的物1.23g(収率97.2%)が得ら
れた。 比旋光度:〔α〕25 D−71.0゜(c1.0、THF) IR値:νCHCl3 nax cm-1 3630、3420(シヨルダー)、1725 PMR値:δCDCl3 ppm 0.23(6H,s)、0.96(9H,s)、 1.7(1H,m)、1.83(1H,br.s)、 2.2(1H,m)、2.72(1H,dd,J=15Hz,
3Hz)、 3.17(1H,dd,J=15Hz,5Hz)、3.68(1H,
m)、 3.74(2H,t,J=7Hz) (c) 4(R)−1−(t−ブチルジメチルシリル)−
4−(2−t−ブチルジメチルシリルオキシエチ
ル)−アゼチジン−2−オンの製造 実施例1(b)で得られたアルコール体1.23g及び
トリエチルアミン0.83mlをジメチルホルムアミド
18mlに溶解し、0℃に冷却して撹拌した。この液
にt−ブチルジメチルクロルシラン886mgを加え、
室温で35分間反応した。反応液より溶媒を留去
し、残渣をエーテルに溶解して水洗及び乾燥した
のち濃縮した。得られた残渣をシリカゲルカラム
クロマトグラフイー(溶媒;塩化メチレン)で精
製すると、無色油状物の目的物1.54g(収率83.4
%)が得られた。 比旋光度:〔α〕25 D−63.0゜(c1,THF) IR値:νCHCl3 nax cm-1 1724 PMR値:δCDCl3 ppm 0.03(6H,s)、0.23(6H,s)、 0.88(9H,s)、0.97(9H,s)、 1.64(1H,m)、2.06(1H,m)、 2.72(1H,dd,J=16Hz,2Hz)、 3.11(1H,dd,J=16Hz,5Hz)、 3.65(1H,m)、3.68(2H,t,J=6Hz) (d) (4R)−1−(t−ブチルジメチルシリル)−
3−イソプロピリデン−4−(2−t−ブチルジ
メチルシリルオキシエチル)−アゼチジン−2−
オンの製造 ジイソプロピルアミン0.207ml及び無水テトラ
ヒドロフラン2.5mlを枝付フラスコに入れ、窒素
雰囲気下−78℃に冷却し撹拌した。これにn−ブ
チルリチウム(1.6Mヘキサン溶液)0.922mlを加
え10分間撹拌し、次いで実施例1(c)で得られたジ
シリル体112mgの無水テトラヒドロフラン1.5ml溶
液を滴下して10分間撹拌したのち、−50℃で更に
15分間撹拌した。反応液を再び−78℃に冷却し、
塩化トリメチルシラン0.045mlを加えて10分間撹
拌したのち、−50℃で15分間撹拌した。反応液を
更に−78℃に冷却し、アセトン0.185mlを加えて
15分間撹拌したのち、飽和塩化アンモニウム水溶
液1.5mlを加え40℃に20分間加温した。反応液を
塩化メチレンで抽出し、抽出液を水洗及び乾燥し
たのち濃縮した。残渣をシリカゲルカラムクロマ
トグラフイー〔擁溶媒:塩化メチレン−エーテル
(15:1)〕で精製すると、無色油状物の目的物
130mgが得られた。(このものは3−トリメチルシ
リル化合物を約25%含有していた)。 IR値:νCHCl3 nax cm-1 1710 PMR値:δCDCl3 ppm 0.03(6H,s)、0.20(3H,s)、 0.24(3H,s)、0.83(9H,s)、 0.94(3H,s)、1.4〜2.2(2H,コンプレツ
クスm) 1.72(3H,s)、2.00(3H,s)、 3.67(2H,t,J=7Hz)、4.20(1H,t,
J=5Hz) (e) (4R)−3−イソプロピリデン−4−(2−
ヒドロキシエチル)−アゼチジン−2−オンの製
[Table] Example 1 Production of (5R)-p-nitrobenzyl 6-isopropylidene-1-azabicyclo[3.2.0]heptane-3,7-dione-2-carboxylate (a) (4S)- 1-(t-butyldimethylsilyl)-
4-(methoxycarbonylmethyl)-azetidine-
Manufacture of 2-one (4S)-4-(methoxycarbonylmethyl)-azetidin-2-one (JACS 103 2405
(1981)) and 2.56 ml of triethylamine were dissolved in 30 ml of dimethylformamide, cooled to 0°C, 2.74 g of t-butyldimethylchlorosilane was added with stirring, and the mixture was further stirred for 50 minutes. After the reaction, dimethylformamide was distilled off, and the residue was dissolved in methylene chloride, washed with water, dried, and concentrated. The residue was subjected to silica gel column chromatography [solvent: n-hexane-ethyl acetate (5:
1)], 3.47g of the target product is obtained as colorless crystals.
(Yield 96.8%) was obtained. Specific optical rotation: [α] 25 D −80° (c1.0, THF) IR value: ν CHCl3 nax cm -1 1743, 1735 PMR value: δ CDCl3 ppm 0.20 (3H, s), 0.23 (3H, s) , 0.93 (9H, s), 2.47 (1H, dd, J=16Hz,
10Hz), 2.76 (1H, dd, J = 16Hz, 3Hz), 2.85 (1H,
dd, J=15Hz, 5Hz), 3.28(1H, dd, J=
15Hz, 6Hz), 3.68 (3H, s), 3.88 (1H, m) (b) (4R)-1-(t-butyldimethylsilyl)-
4-(2-hydroxyethyl)-azetidine-2-
on manufacturing 270 mg of lithium aluminum hydride was suspended in 70 ml of anhydrous ether, cooled to -20°C under nitrogen atmosphere, and stirred to obtain the ester compound obtained in Example 1(a).
Drop a solution of 1.42g in 70ml of anhydrous ether to -20°C.
The mixture was stirred for 10 minutes. 2N hydrochloric acid was added to the reaction solution to decompose excess reagent, followed by extraction with ether.
The extract was washed with water, dried, and then concentrated to obtain 1.23 g (yield: 97.2%) of the desired product as a colorless oil. Specific optical rotation: [α] 25 D −71.0° (c1.0, THF) IR value: ν CHCl3 nax cm -1 3630, 3420 (shoulder), 1725 PMR value: δ CDCl3 ppm 0.23 (6H, s), 0.96 (9H, s), 1.7 (1H, m), 1.83 (1H, br.s), 2.2 (1H, m), 2.72 (1H, dd, J=15Hz,
3Hz), 3.17 (1H, dd, J = 15Hz, 5Hz), 3.68 (1H,
m), 3.74 (2H, t, J = 7Hz) (c) 4(R)-1-(t-butyldimethylsilyl)-
Production of 4-(2-t-butyldimethylsilyloxyethyl)-azetidin-2-one 1.23 g of the alcohol obtained in Example 1(b) and 0.83 ml of triethylamine were dissolved in dimethylformamide.
The mixture was dissolved in 18 ml, cooled to 0°C, and stirred. Add 886 mg of t-butyldimethylchlorosilane to this solution,
The reaction was carried out at room temperature for 35 minutes. The solvent was distilled off from the reaction solution, and the residue was dissolved in ether, washed with water, dried, and then concentrated. The resulting residue was purified by silica gel column chromatography (solvent: methylene chloride) to obtain 1.54 g of the desired product as a colorless oil (yield: 83.4
%)was gotten. Specific optical rotation: [α] 25 D −63.0° (c1, THF) IR value: ν CHCl3 nax cm -1 1724 PMR value: δ CDCl3 ppm 0.03 (6H, s), 0.23 (6H, s), 0.88 (9H , s), 0.97 (9H, s), 1.64 (1H, m), 2.06 (1H, m), 2.72 (1H, dd, J=16Hz, 2Hz), 3.11 (1H, dd, J=16Hz, 5Hz) , 3.65 (1H, m), 3.68 (2H, t, J = 6Hz) (d) (4R)-1-(t-butyldimethylsilyl)-
3-isopropylidene-4-(2-t-butyldimethylsilyloxyethyl)-azetidine-2-
on manufacturing 0.207 ml of diisopropylamine and 2.5 ml of anhydrous tetrahydrofuran were placed in a side-armed flask, and the mixture was cooled to -78°C and stirred under a nitrogen atmosphere. To this was added 0.922 ml of n-butyllithium (1.6M hexane solution) and stirred for 10 minutes. Next, a solution of 1.5 ml of anhydrous tetrahydrofuran containing 112 mg of the disilyl compound obtained in Example 1(c) was added dropwise and stirred for 10 minutes. , further at −50℃
Stir for 15 minutes. The reaction solution was cooled again to −78°C,
After adding 0.045 ml of trimethylsilane chloride and stirring for 10 minutes, the mixture was stirred at -50°C for 15 minutes. The reaction solution was further cooled to -78℃, and 0.185ml of acetone was added.
After stirring for 15 minutes, 1.5 ml of saturated ammonium chloride aqueous solution was added and heated to 40°C for 20 minutes. The reaction solution was extracted with methylene chloride, and the extract was washed with water, dried, and then concentrated. When the residue was purified by silica gel column chromatography [solvent: methylene chloride-ether (15:1)], the desired product was obtained as a colorless oil.
130mg was obtained. (This contained about 25% 3-trimethylsilyl compound). IR value: ν CHCl3 nax cm -1 1710 PMR value: δ CDCl3 ppm 0.03 (6H, s), 0.20 (3H, s), 0.24 (3H, s), 0.83 (9H, s), 0.94 (3H, s) , 1.4~2.2 (2H, complex m) 1.72 (3H, s), 2.00 (3H, s), 3.67 (2H, t, J=7Hz), 4.20 (1H, t,
J=5Hz) (e) (4R)-3-isopropylidene-4-(2-
Production of hydroxyethyl)-azetidin-2-one

【式】 実施例1(d)で得られたジシリル体(3−イソプ
ロピリデン化合物と3−トリメチルシリル化合物
の約3:1混合物)1.124gをメタノール−水
(9:1)の混液31.25mlに溶解し、0℃に冷却し
て撹拌し、濃塩酸1.03mlを加えて0℃で1.5時間
撹拌した。反応液を飽和炭酸水素ナトリウム水溶
液で中和し、メタノールを留去した。残渣を酢酸
エチルで抽出し、抽出液を乾燥後、濃縮した。残
渣をシリカゲルカラムクロマトグラフイー(溶
媒:酢酸エチル)で精製すると、無色結晶の目的
物342mg(実施例1(d)及び1(e)の収率75.4%)が
得られた。 IR値:νCHCl3 nax cm-1 3440、1730 PMR値:δCDCl3 ppm 1.72(3H,s)、2.02(3H,s)、 1.5〜2.3(2H,コンプレツクスm) 3.77(2H,t,J=6Hz) 4.20(1H,dd,J=9Hz,2Hz) (f) (4R)−3−イソプロピリデン−4−カルボ
キシメチル−アゼチジン−2−オンの製造 実施例1(e)で得られたアルコール体66mgをピリ
ジン0.4mlに溶解し、クロム酸180mgのピリジン
3.9ml溶液を加えて室温で19時間撹拌した。反応
液を酢酸エチルで抽出し、抽出液を飽和食塩水−
亜硫酸水素ナトリウムで洗浄後、乾燥して濃縮す
ると、淡黄色の油状物が得られた。この油状物を
酢酸エチルに溶解し、飽和炭酸水素ナトリウム水
溶液で抽出し、酢酸エチルで洗浄した。抽出液を
2Nの塩酸で酸性としたのち酢酸エチルで抽出し、
乾燥後濃縮すると、淡黄色結晶の目的物52mg(収
率72.3%)が得られた。 IR値:νCHCl3 nax cm-1 3430、1725、1715 PMR値:δCDCl3 ppm 1.72(3H,s)、2.00(3H,s)、 2.48(1H,dd,J=17Hz,10Hz)、 2.90(1H,dd,J=17Hz,3Hz)、 4.35(1H,dd,J=10Hz,3Hz)、 7.50(1H,br,s)、9.24(1H,br,s) (g) (4R)−3−イソプロピリデン−4−〔3−
(p−ニトロベンジル)オキシカルボニル−2−
オキソプロピル〕−アゼチジン−2−オンの製造 実施例1(f)で得られたカルボン酸418mgをテト
ラヒドロフラン15.2mlに溶解し、窒素雰囲気下で
N,N′−カルボニルジイミダゾール441.5mgを加
え、1時間50分撹拌した。 一方、マロン酸モノp−ニトロベンジル845mg
を無水テトラヒドロフラン9mlに溶解し、窒素雰
囲気下で撹拌しながらマグネシウムメトキシド
152.6mgを加え1時間撹拌した。反応液より、減
圧下に溶媒を留去し、この残渣に先に合成したイ
ミダゾライド溶液を加え、室温で20時間撹拌し
た。反応液を濃縮し、残渣を酢酸エチル−0.3N
塩酸(5:1)で抽出して抽出液を炭酸水素ナト
リウム水溶液で洗浄後、乾燥し濃縮すると、褐色
の油状物が得られた。これをシリカゲルカラムク
ロマトグラフイー(溶媒:酢酸エチル)で精製す
ると、淡黄色油状物として、目的物798mg(収率
93.2%)が得られた。 IR値:νCHCl3 nax cm-1 3440、1745、1720(シヨルダー) PMR値:δCDCl3 ppm 1.70(3H,s)、2.04(3H,s)、 2.75(1H,dd,J=18Hz,10Hz)、 3.16(1H,dd,J=18Hz,3Hz)、 3.58(2H,s)、4.38(1H,dd,J=10Hz,
3Hz)、 5.26(2H,s)、6.30(1H,br,s)、 7.52(2H,d,J=8Hz)、8.22(2H,d,J
=8Hz) (h) (4R)−3−イソプロピリデン−4−〔3−
(p−ニトロベンジル)オキシカルボニル−2−
オキソ−3−ジアゾプロピル〕−アゼチジン−2
−オンの製造 実施例1(g)で得られたケトエステル体758mg及
びアジ化p−トルエンスルホニル587mgをアセト
ニトリル30mlに溶解し、0℃に冷却して撹拌しな
がらトリエチルアミン800mgを添加して室温で30
分間撹拌した。反応液を濃縮し、残渣をシリカゲ
ル薄層クロマトグラフイー〔溶媒;n−ヘキサン
−酢酸エチル(1:1)〕で精製すると、淡黄色
半固体として目的物572mg(収率70.2%)が得ら
れた。 IR値:νCHCl3 nax cm-1 3440、2130、1725(ブロード) PMR値:δCDCl3 ppm 1.72(3H,s)、2.01(3H,s) 2.90(1H,dd,J=18Hz,10Hz) 3.50(1H,dd,J=18Hz,3Hz) 4.36(1H,dd,J=9Hz,3Hz)、5.34(2H,
s) 6.48(1H,br,s)、7.50(2H,d,J=
8Hz) 8.20(2H,d,J=8Hz) (i) (5R)p−ニトロベンジル6−イソプロピ
リデン−1−アザビシクロ〔3.2.0〕ヘプタン−
3,7−ジオン−2−カルボキシレートの製造 実施例1(h)で得られたジアゾ体572mg及び酢酸
ロジウム1.7mgに脱気した無水ベンゼン46mlを加
え、窒素雰囲気下に浴温78℃で1時間加熱した。
冷後、不溶物を去し、液を濃縮すると、淡褐
色結晶の目的物537mg(定量的)が得られた。 IR値:νCHCl3 nax cm-1 1750 PMR値:δCDCl3 ppm 1.81(3H,s)、2.09(3H,s) 2.40(1H,dd,J=19Hz,7Hz)、 2.87(1H,dd,J=19Hz,7Hz)、 4.56(1H,t,J=7Hz)、4.67(1H,s) 5.20(1H,d,J=14Hz)、5.36(1H,d,
J=14Hz)、 7.51(2H,d,J=8Hz)8.17(2H,d,J
=8Hz) 実施例 2 (5R)p−ニトロベンジル6−イソプロピリ
デン−3−(2−アセチルアミノエチルチオ)−1
−アザビシクロ〔3.2.0〕ヘプト−2−エン−7
−オン−2−カルボキシレートの製造 実施例1で得られたビシクロケトン体すなわち
(5R)p−ニトロベンジル6−イソプロピリデン
−1−アザビシクロ〔3.2.0〕ヘプタン−3,7
−ジオン−2−カルボキシレート100mgをアセト
ニトリル5.8mlに溶解し、0℃に冷却して撹拌下
に4−ジメチルアミノピリジン4mg及びジイソプ
ロピルエチルアミン0.063mlを加え、1分間反応
後、塩化リン酸ジフエニル93.3mgをアセトニトリ
ル1mlに溶解した溶液を0℃に冷却して加えた。
10分間反応したのち、−25℃に冷却し、ジイソプ
ロピルエチルアミン0.215mlを添加し、直ちにN
−アセチルシステアミン76.4mgをアセトニトリル
2mlに溶解して加え、0℃で1時間反応し、冷蔵
庫中に17時間放置した。反応液に酢酸エチルを加
え、水洗及び乾燥したのち濃縮すると赤色油状物
が得られた。これをシリカゲルカラムクロマトグ
ラフイー〔溶媒;塩化メチレン−メタノール
(20:1)〕で精製すると、淡黄色結晶として目的
物85mg(収率65.7%)が得られた。 比旋光度:〔α〕24 D −10.0゜(c1.0、THF) IR値:νCHCl3 nax cm-1 3470、1765、1700、1670 UV値:λTHF nax nm 297(ε=11320)、289(ε=11680) 267(ε=12990)、244(ε=13940) PMR値:δCDCl3 ppm 1.82(3H,s)、1.95(3H,s) 2.10(3H,s)、2.7〜3.6(6H,コンプレツク
スm) 4.72(1H,t,J=9Hz)、5.21(1H,d,J
=14Hz) 5.52(1H,d,J=14Hz)、6.04(1H,br,
s) 7.66(2H,d,J=9Hz)、8.20(2H,d,J
=9Hz) 実施例 3 (5R)p−ニトロベンジル6−イソプロピリ
デン−3−(2−ヒドロキシエチルチオ)−1−ア
ザビシクロ〔3.2.0〕ヘプト−2−エン−7−オ
ン−2−カルボキシレートの製造 実施例1で得られたビシクロケトン体131mg及
び2−メルカプトエタノール69.8mgを用い、実施
例2と同様に反応処理を行い、シリカゲルカラム
クロマトグラフイー(溶媒:酢酸エチル)で精製
すると、無色結晶として目的物51mg(収率33.2
%)が得られた。 比旋光度;〔α〕22 D +9.0゜(c1.0、THF) IR値:νCHCl3 nax cm-1 3500(ブロード)、1765、1700 UV値:λTHF nax nm 300(ε=10530)、266(ε=10810) 244(ε=12540) PMR値;δCDCl3 ppm 1.80(3H,s)、2.00(1H,br.) 2.09(3H,s)、2.8〜3.6(4H,コンプレツク
スm) 3.72〜4.00(2H,コンプレツクスm)、 4.68(1H,t,J=8Hz)、5.20(1H,d,J
=14Hz) 5.50(1H,d,J=14Hz)、7.64(2H,d,
J=8Hz) 8.18(2H,d,J=8Hz) 実施例 4 (5R)p−ニトロベンジル6−イソプロピリ
デン−3−フエニルチオ−1−アザビシクロ
〔3.2.0〕ヘプト−2−エン−7−オン−2−カル
ボキシレートの製造 実施例1で得られたビシクロケトン体110mg及
びチオフエノール82.6mgを用い、実施例2と同様
に反応、処理を行い、シリカゲルカラムクロマト
グラフイー〔溶媒;塩化メチレン−酢酸エチル
(10:1)〕で精製すると、淡黄色粉末として目的
物19mg(収率13.6%)が得られた。 比旋光度;〔α〕22 D −92.6゜(c0.95、THF) IR値;νCHCl3 nax cm-1 1760、1700 UV値;λTHF nax nm 331(ε=7490)、289(ε=11930) 266(ε=13090)、254(ε=14280) PMR値;δCDCl3 ppm 1.68(3H,s)、2.06(3H,s) 2.63(2H,d,J=9Hz)、4.54(1H,t,J
=8Hz) 5.25(1H,d,J=14Hz)、5.56(1H,d,
J=14Hz) 7.2〜7.7(5H,m)、7.68(2H,d,J=8Hz) 8.19(2H,d,J=8Hz) 実施例 5 (5R)p−ニトロベンジル6−イソプロピリ
デン−3−(2−ピリミジニルチオ)−1−アザビ
シクロ〔3.2.0〕ヘプト−2−エン−7−オン−
2−カルボキシレートの製造 実施例1で得られたビシクロケトン体100mg及
び2−メルカプトピリミジン71.8mgを用い、実施
例2と同様に反応・処理を行い、シリカゲルカラ
ムクロマトグラフイー(溶媒;エーテル)で精製
すると、淡黄色結晶として目的物75mg(収率58.9
%)が得られた。 比旋光度:〔α〕24 D −79.5゜(c1.9、THF) IR値;νCHCl3 nax cm-1 1770、1705 UV値;λTHF nax nm 330(ε=12640)、321(ε=13500) 290(ε=17400)、247(ε=25100) PMR値:δCDCl3 ppm 1.80(3H,s)、2.11(3H,s) 3.10(1H,dd,J=18Hz,8Hz) 3.86(1H,dd,J=18Hz,11Hz) 4.80(1H,m)、5.28(1H,d,J=14Hz) 5.52(1H,d,J=14Hz)、7.07(1H,t,
J=4Hz) 7.66(2H,d,J=9Hz)、8.19(2H,d,J
=9Hz) 8.54(2H,d,J=4Hz) 実施例 6 (5R)p−ニトロベンジル6−イソプロピリ
デン−3−(2−ピリジルチオ)−1−アザビシク
ロ〔3.2.0〕ヘプト−2−エン−7−オン−2−
カルボキシレートの製造 実施例1で得られたビシクロケトン体120mg及
び2−メルカプトピリミジン91.2mgを用い、実施
例2と同様に反応・処理を行い、シリカゲルカラ
ムクロマトグラフイー(溶媒;エーテル)で精製
すると、黄色結晶として目的物83mg(収率54.3
%)が得られた。 比旋光度;〔α〕24 D −71.1゜(c4.15、THF) IR値;νCHCl3 nax cm-1 1770、1700 UV値;λTHF nax nm 289(ε=14050)、262.5(ε=16600) 246(ε=18600) PMR値;δCDCl3 ppm 1.74(3H,s)、2.05(3H,s) 2.90(1H,dd,J=18Hz,8Hz) 3.29(1H,dd,J=18Hz,10Hz) 4.69(1H,dd,J=10Hz,8Hz) 5.30(1H,d,J=14Hz)、5.56(1H,d,
J=14Hz) 6.9〜7.3(1H,m) 7.35〜7.8(2H,コンプレツクスm) 7.69(2H,d,J=8Hz)、8.20(2H,d,J
=8Hz) 8.56(1H,br,d,J=4Hz) 実施例 7 (5R)6−イソプロピリデン−3−(2−アセ
チルアミノエチルチオ)−1−アザビシクロ
〔3.2.0〕ヘプト−2−エン−7−オン−2−カル
ボン酸ナトリウム塩の製造 実施例2で得られたp−ニトロベンジルエステ
ル体85mgを、ジオキサン6mlとPH7.6の0.1Mリン
酸緩衝液3.1mlの混液に溶解し、5%パラジウム
炭素90mgを加えて水素(1気圧)雰囲気下に3時
間撹拌した。反応液より触媒を去し、液を酢
酸エチルで洗浄後、水層に5%濃度になる様に食
塩を添加した。これをダイヤイオンHP−20(25
ml)のカラムに吸着させ、水洗後30%メタノール
水で溶出し、目的物を含む画分を集めた。これを
濃縮したのち凍結乾燥すると淡黄色粉末として目
的のナトリウム塩25.9mg(収率40.8%)が得られ
た。 比旋光度;〔α〕24 D −26.1゜(c0.88,H2O) IR値;νKBr nax cm-1 1770,1650,1600 UV値;λPBS nax(PH7.0) nm(ε) 284(5689),238(12710) PMR値;δD2O ppm(重水を4.80として) 1.93(3H,s)、2.06(3H,s) 2.13(3H,s)、2.8〜4.0(6H,コンブレ
ツクスm)、4.78(1H,m) 実施例 8 (5R)6−イソプロピリデン−3−(2−ヒド
ロキシエチルチオ)−1−アザビシクロ〔3.2.0〕
ヘプト−2−エン−7−オン−2−カルボン酸ナ
トリウム塩の製造。 実施例3で得られたp−ニトロベンジルエステ
ル化合物51mgを、ジオキサン2.66mlとPH7.2の
0.1Mリン酸緩衝液1.86mlの混液に溶解し、5%
パラジウム炭素54mgを加え、水素(1気圧)雰囲
気下に2時間撹拌した。これを実施例7と同様に
処理、精製すると、無色粉末としてナトリウム塩
8.5mg(収率23.2%)が得られた。 比旋光度;〔α〕22 D +6.89゜(c0.145,H2O) IR値;νKBr nax cm-1 1770,1600(ブロード) UV値;λPBS nax(PH7.0) nm(ε) 285(6740),239(14470) PMR値;δD2O (重水を4.80として)ppm 1.97(3H,s)、2.14(3H,s) 2.95〜3.40(4H,コンプレツクスm)、
3.84(2H,t,J=6Hz)、4.72(1H,
m) 実施例 9 (5R)6−イソプロピリデン−3−フエニル
チオ−1−アザビシクロ〔3.2.0〕ヘプト−2−
エン−7−オン−2−カルボン酸ナトリウム塩の
製造 実施例4で得られたp−ニトロベンジルエステ
ル体19mgをジオキサン0.7mlとPH7.2の0.1Mリン酸
緩衝液0.7mlの混液に溶解し、5%パラジウム炭
素20mgを加えて水素(1気圧)雰囲気下に2時間
撹拌した。反応液より溶媒を去し、液を酢酸
エチルで洗浄すると目的のナトリウム塩の水溶液
(7倍希釈液のO.D.;0.672)25mlが得られた。 UV値;λPBS(PH7.2) max nm 280 実施例 10 (5R)6−イソプロピリデン−3−(2−ピリ
ミジニルチオ)−1−アザビシクロ〔3.2.0〕ヘプ
ト−2−エン−7−オン−2−カルボン酸の製造 実施例5で得られたp−ニトロベンジルエステ
ル体67mgを、ジオキサン4.7mlとPH7.2の0.1Mリン
酸緩衝液4.7mlの混液に溶解し、5%パラジウム
炭素70mgを加え、水素(1気圧)雰囲気下に3時
間撹拌した。これを実施例7と同様に処理、精製
すると、淡黄色粉末として目的のカルボン酸29.7
mg(収率64.0%)が得られた。 比旋光度;〔α〕24 D −194゜(c1,H2O) IR値;νKBr nax cm-1 1760,1700,1560,1540 UV値;λPBS nax(PH7.0) nm(ε) 280(11900),243(21300) PMR値;δD2O ppm(重水を4.80として) 1.87(3H,s)、2.12(3H,s) 2.93(1H,dd,J=18Hz,8Hz)、3.48
(1H,dd,J=18Hz,10Hz) 4.79(1H,m)、7.39(1H,t,J=
5Hz) 8.68(2H,d,J=5Hz) 実施例 11 (5R)6−イソプロピリデン−3−(2−ピリ
ジルチオ)−1−アザビシクロ〔3.2.0〕ヘプト−
2−エン−7−オン−2−カルボン酸の製造 実施例6で得られたp−ニトロベンジルエステ
ル体83mgを、ジオキサン4mlとPH7.2の0.1Mリン
酸緩衝液2.4mlの混液に溶解し、5%パラジウム
炭素85mgを加えて水素(1気圧)雰囲気下に3時
間撹拌した。これを実施例7と同様に処理、精製
すると、淡黄色粉末として、目的のカルボン酸
16.3mg(収率28.4%)が得られた。 比旋光度;〔α〕24 D −142.2゜(c0.45,H2O) IR値;νKBr nax cm-1 1740,1602,1575,1560 UV値;λPBS nax(PH7.0) nm(ε) 291,241(15680) PMR値;δD2O ppm(重水を4.80として) 1.83(3H,s)、2.14(3H,s) 2.76(1H,dd,J=17Hz,8Hz)、 3.01(1H,dd,J=17Hz,10Hz) 4.75(1H,m)、7.49(1H,dd,J=
6Hz,4Hz)、7.68(1H,d,J=8Hz)、 7.92(1H,m)、8.56(1H,br.d,J=
4Hz) 実施例 12 (5R)p−ニトロベンジル6(z)−〔1−メチ
ル−2−(p−ニトロベンジル)オキシカルボニ
ルオキシエチリデン〕−1−アザビシクロ
〔3.2.0〕ヘプタ−3,7−ジオン−2−カルボキ
シレートの製造 (a) (4R)1−(t−ブチルジメチルシリル)−
3(Z及びE)−(1−メチル−2−ヒドロキシ)
エチリデン−4−(2−t−ブチルジメチルシリ
ル)オキシエチル−アゼチジン−2−オンの製造 実施例1(d)で得られたイソプロピリデン体(3
−トリメチルシリル化合物約25%を含有してい
る)984mgをジオキサン20mlに溶解し、浴温105℃
で撹拌しながらこれに二酸化セレン218mgをジオ
キサン−水(5:1)の混液12mlに溶解した液を
滴下し41.5時間撹拌した。途中、14時間経過後に
上記と同量の二酸化セレンのジオキサン−水溶液
を加えて。反応後、不溶物を去し、液を濃縮
したのち、残渣を酢酸エチルに溶解した。これを
水洗後、炭酸水素ナトリウムの飽和水溶液で洗浄
し、乾燥したのち濃縮すると、黄色油状物1.0g
が得られた。この油状物をメタノールに溶解し、
氷冷下水素化ホウ素ナトリウム40mgを加え、70分
間撹拌した。反応液を濃縮し、残渣を酢酸エチル
に溶解して水洗・乾燥後濃縮すると褐色油状物
1.0gが得られた。これをシリカゲルカラムクロ
マトグラフイー〔溶媒;n−ヘキサン−酢酸エチ
ル(6:1)〕で精製すると、無色油状物のZ体
270mg(収率35.3%)及びE体110mg(収率14.4
%)が得られた。 Z体 IR値;νCHCl3 nax cm-1 3340(ブロード)、1695 PMR値;δCDCl3 ppm 0.04(6H,s)、0.26(3H,s) 0.30(3H,s)、0.70(9H,s) 0.98(9H,s)、1.72(3H,s) 1.60〜2.06(2H,コンプレツクスm)、 3.72(2H,t,J=6Hz)、4.25(3H,コ
ンプレツクスm) E体 IR値;νCHCl3 nax cm-1 1720 NMR値;δCDCl3 ppm 0.06(6H,s)、0.21(3H,s) 0.25(3H,s)、0.90(9H,s) 0.97(9H,s)、1.60〜2.19(2H,コンプ
レツクスm)、2.02(3H,s)、 3.77(2H,t,J=6Hz)、4.10(2H,
s)、 4.40(1H,m) (b) (4R)1−(t−ブチルジメチルシリル)−
3(Z)−〔1−メチル−2−(p−ニトロベンジ
ル)オキシカルボニルオキシエチリデン〕−4−
(2−t−ブチルジメチルシリルオキシエチル)−
アゼチジン−2−オンの製造 実施例12(a)で得られたZ−アルコール体270mg
を塩化メチレン3mlに溶解し、0℃に冷却してト
リエチルアミン0.113mlと4−ジメチルアミノピ
リジン8.3mgを加えたのち、塩化ギ酸p−ニトロ
ベンジルエステル175mgを塩化メチレン1mlに溶
解して加え、0℃で30分間、続いて室温で22時間
撹拌した。途中、1時間及び3時間経過した時に
反応液を0℃に冷却し、トリエチルアミン、4−
ジメチルアミノピリジン及び塩化ギ酸p−ニトロ
ベンジルエステルの塩化メチレン溶液をそれぞれ
上記の2倍量加え、更に7時間経過時に上記と同
量加えた。反応終了後、反応液に塩化メチレンを
加え、水洗、乾燥後濃縮した。黄色固体の残渣を
シリカゲルカラムクロマトグラフイー〔溶媒;n
−ヘキサン−酢酸エチル(10:1)〕で精製する
と、無色粉末の目的物267mg(収率68.3%)が得
られた。 IR値;νCHCl3 nax cm-1 1730、1610 PMR値;δCDCl3 ppm 0.04(6H,s)、0.24(3H,s) 0.28(3H,s)、0.85(9H,s) 0.96(9H,s)、1.83(3H,s) 1.60〜2.06(2H,コンプレツクスm)、 3.72(2H,t,J=6Hz)、4.30(1H,
t,J=4Hz)、5.10(2H,s)、 5.24(2H,s)、7.55(2H,d,J=
9Hz)、8.18(2H,d,J=9Hz) (c) (4R)3(Z)−〔1−メチル−2−(p−ニ
トロベンジル)オキシカルボニルオキシエチリデ
ン〕−4−(2−ヒドロキシエチル)−アゼチジン
−2−オンの製造 実施例12(b)で得られたジシリル化合物267mgを
メタノール−水(9:1)の混液10mlに溶解し、
0℃に冷却して濃塩酸0.165mlを加えて15分間撹
拌したのち、水冷下で4時間30分撹拌した。反応
液を炭酸水素ナトリウムの飽和水溶液でPH8に調
整したのち、メタノールを留去し、酢酸エチルで
抽出した。有機層を乾燥したのち濃縮し、残渣を
n−ヘキサンで洗浄すると、無色結晶の目的物
165mg(定量的)が得られた。 PMR値;δ CDCl3−CD3OD(6:1) ppm 1.82(3H,s)、1.60〜2.15(2H,コンプ
レツクスm)、3.70(2H,t,J=
6Hz)、 4.25(1H,dd,J=9Hz,3Hz)、5.03
(2H,s)、5.29(2H,s)、7.59(2H,
d,J=9Hz)、8.22(2H,d,J=
9Hz) (d) (4R)3(Z)−〔1−メチル−2−(p−ニ
トロベンジル)オキシカルボニルオキシエチリデ
ン〕−4−カルボキシメチル−アゼチジン−2−
オンの製造 実施例12(c)で得られたアルコール体165mgをピ
リジン5mlに溶解し、クロム酸483mgをピリジン
7mlに溶解して加え、室温で14時間撹拌した。反
応液に水100mlを加えたのち、酢酸エチルで抽出
し、乾燥、濃縮して得られる残渣を酢酸エチルに
溶解し、炭酸水素ナトリウムの飽和水溶液で抽出
した。これを酢酸エチルで洗浄したのち、再び酢
酸エチルを加え、0.5規定の塩酸でPHを1に調整
した。これを塩析下に酢酸エチルで抽出し、乾燥
後濃縮すると淡黄色油状物として、目的物121mg
(収率70.5%)が得られた。 IR値;νCHCl3 nax cm-1 3320(ブロード)、1740,1610 PMR値;δCDCl3 ppm 1.80(3H,s)、2.23〜3.15(2H,コンプ
レツクスm)、4.23〜4.55(1H,m)、 5.02(2H,s)、5.23(2H,s)、 7.52(2H,d,J=9Hz)、8.19(2H,
d,J=9Hz) (e) (4R)3(Z)−〔1−メチル−2−(p−ニ
トロベンジル)オキシカルボニルオキシエチリデ
ン〕−4−〔3−(p−ニトロベンジル)オキシカ
ルボニル−2−オキソプロピル〕−アゼチジン−
2−オンの製造 実施例12(d)で得られたカルボン酸121mgを無水
テトラヒドロフラン3.0mlに溶解し、窒素雰囲気
下にN,N′−カルボニルイミダゾール59.2mgを加
えて室温で2時間撹拌した。一方、マロン酸モノ
p−ニトロベンジルエステル113.6mgを無水テト
ラヒドロフラン2mlに溶解し、窒素雰囲気下で撹
拌しながらマグネシウムメトキシド46.7mgを加
え、室温で1時間撹拌した。反応液より、減圧下
に溶媒を留去し、この残渣に先に合成したイミダ
ゾライド溶液を加えて、室温で17.5時間撹拌し
た。反応液を濃縮し、残渣を酢酸エチルと0.3規
定塩酸の混液に溶解して有機層を分取し、水層を
更に酢酸エチルで抽出した。有機層を合し、炭酸
水素ナトリウムの飽和水溶液で洗浄したのち、乾
燥して濃縮すると黄色油状物が得られた。これを
シリカゲルカラムクロマトグラフイー〔溶媒;ク
ロロホルム−メタノール(6:1)〕で精製する
と、無色油状物として目的物115mg(収率63.9%)
が得られた。 IR値;νCHCl3 nax cm-1 1760,1610 PMR値;δCDCl3 ppm 1.75(3H,s)、2.79(1H,dd,J=
8Hz,10Hz)、3.20(1H,dd,J=
18Hz,3Hz)、3.60(2H,s)、4.22
(1H,dd,J=10Hz,3Hz)、5.02(2H,
s)、 5.24(4H,s)、6.85(1H,s)、7.47
(2H,d,J=9Hz)、7.50(2H,d,J
=9Hz)、8.18(4H,d,J=9Hz) (f) (4R)3(Z)−〔1−メチル−2−(p−ニ
トロベンジル)オキシカルボニルオキシエチリデ
ン〕−4−〔3−(p−ニトロベンジル)オキシカ
ルボニル−2−オキソ−3−ジアゾプロピル〕−
アゼチジン−2−オンの製造 実施例12(e)で得られたβ−ケトエステル体115
mg及びアジ化p−トルエンスルホニル0.039mlを
アセトアニリル3.9mlに溶解し、0℃で撹拌しな
がらトリエチルアミン0.086mlを加え、室温で1
時間20分撹拌した。反応液を濃縮して得られた淡
黄色油状物をシリカゲルカラムクロマトグラフイ
ー〔溶媒;クロロホルム−メタノール(15:1)〕
で精製すると、無色油状物として目的物114mg
(収率94.6%)が得られた。 IR値;νCHCl3 nax cm-1 2140,1760、1720 PMR値;δCDCl3 ppm 1.79(3H,s)、2.97(1H,dd,J=
18Hz,9Hz)、3.52(1H,dd,J=
18Hz,3Hz)、4.42(1H,dd,J=9Hz,
3Hz)、5.02(2H,s)、5.23(2H,s)、
5.36(2H,s)、6.89(1H,s)、 7.52(4H,d,J=9Hz)、8.18(4H,
d,J=9Hz) (g) (5R)p−ニトロベンジル6(z)−〔1−メ
チル−2−(p−ニトロベンジル)オキシカルボ
ニルオキシエチリデン〕−1−アザビシクロ
〔3.2.0〕ヘプタ−3,7−ジオン−2−カルボキ
シレートの製造 実施例12(f)で得られたジアゾ体114mg及び酢酸
ロジウム0.171mgに脱気した無水ベンゼン5.15ml
を加え、窒素雰囲気下、浴温78℃で1時間20分加
熱した。冷却後、不溶物を去し、液を濃縮す
ると、淡黄色油状物として、目的物114mg(定量
的)が得られた。 IR値;νCHCl3 nax cm-1 1760,1610 PMR値;δCDCl3 ppm 1.82(3H,s)、2.43(1H,dd,J=
18Hz,6Hz)、2.90(1H,dd,J=
18Hz,6Hz)、4.59(1H,t,J=
6Hz)、4.71(1H,s)、5.00(2H,s)、
5.22(4H,s)、7.48(4H,d,J=
9Hz)、8.15(4H,d,J=9Hz) 実施例 13 (5R)p−ニトロベンジル6(z及びE)−〔1
−メチル−2−(p−ニトロベンジル)オキシカ
ルボニルオキシエチリデン〕−3−(2−ピリミジ
ニルチオ)−1−アザビシクロ〔3.2.0〕ヘプト−
2−エン−7−オン−2−カルボキシレートの製
実施例12で得られたビシクロケトン体114mgを
アセトニトリル4.2mlに溶解し、0℃に冷却して
撹拌下にジイソプロピルエチルアミン0.041ml及
び4−ジメチルアミノピリジン2.8mgを加えたの
ち、塩化リン酸ジフエニル0.046mlをアセトニト
リル1mlに溶解した液を0℃に冷却して加え、10
分間撹拌した。反応液を−25℃に冷却し、ジイソ
プロピルエチルアミン0.177mlを加えたのち、直
ちに2−メルカプトピリミジン49.5mgを加え、0
℃で30分間撹拌して、冷蔵庫中に13時間保存し
た。反応液に酢酸エチルを加えたのち、飽和食塩
水で洗浄し、乾燥後濃縮すると、褐色油状物が得
られた。これをシリカゲルカラムクロマトグラフ
イー〔溶媒;クロロホルム−メタノール(30:
1)〕で精製したのち、更にシリカゲルカラムク
ロマトグラフイー〔溶媒;n−ヘキサン−酢酸エ
チル(1:3)〕で分離すると、無色油状物とし
てZ体5.8mg(収率4.3%)及びE体22mg(収率
16.5%)が得られた。 Z体 比旋光度;〔α〕23 D −79.0゜(c0.29,THF) IR値;νCHCl3 nax cm-1 3280(ブロード),1760,1610 PMR値;δCDCl3 ppm 1.85(3H,s)、3.18(1H,dd,J=
18Hz,9Hz)、3.92(1H,dd,J=
18Hz,10Hz)、4.82(1H,m)、 5.04(2H,s)、5.25(2H,s)、 5.27(1H,d,J=14Hz)、5.53(1H,
d,J=14Hz)、7.05(1H,t,J=
5Hz)、 7.50(2H,d,J=9Hz)、7.62(2H,
d,J=9Hz)、8.19(4H,d,J=
9Hz)、 8.55(2H,d,J=5Hz) E体 比旋光度;〔α〕23 D −27.0゜(c1,THF) IR値;νCHCl3 nax cm-1 1770,1720(シヨルダー)、1610 PMR値;δCDCl3 ppm 2.10(3H,s)、3.18(1H,dd,J=
18Hz,9Hz)、3.82(1H,dd,J=
18Hz,10Hz)、 4.70(2H,s)、4.70〜4.90(1H,m)、 5.22(2H,s)、5.26(1H,d,J=
14Hz)、 5.52(1H,d,J=14Hz)、7.02(1H,
t,J=5Hz)、7.45(2H,d,J=
9Hz)、 7.62(2H,d,J=9Hz)、8.18(4H,
d,J=9Hz)、8.45(2H,d,J=
5Hz) 実施例 14 (5R)6(z)−(1−メチル−2−ヒドロキシ
エチリデン)−3−(2−ピリミジニルチオ)−1
−アザビシクロ〔3.2.0〕ヘプト−2−エン−7
−オン−2−カルボン酸の製造 実施例13で得られたp−ニトロベンジルエステ
ル体5.4mgをジオキサン0.5mlとPH7.0の0.1Mリン
酸緩衝液0.3mlの混液に溶解し、5%パラジウム
−炭素8mgを加え、水素(1気圧)雰囲気下、室
温で2時間撹拌した。反応後、触媒を去し、
液を酢酸エチルで洗浄すると、目的物の水溶液
3.0mlが得られた。 UV値;λPBS nax(PH7.0) nm 242 実施例 15 (5R)6(E)−(1−メチル−2−ヒドロキシ
エチリデン)−3−(2−ピリミジニルチオ)−1
−アザビシクロ〔3.2.0〕ヘプト−2−エン−7
−オン−2−カルボン酸の製造 実施例13で得られたp−ニトロベンジルエステ
ル体82.7mgをジオキサン3.5mlとPH7.0のリン酸緩
衝液3.5mlの混液に溶解し、5%パラジウム炭素
83mgを加えて、水素(1気圧)雰囲気下に2時間
撹拌した。これを実施例7と同様に処理、精製す
ると、無色粉末の目的物25.3mg(収率60.7%)が
得られた。 比旋光度;〔α〕18 D −186.7゜(c0.375,H2O) IR値;νKBr nax cm-1 3430(ブロード)、1740、1610、 1560 UV値;λH2O nax nm(ε) 239.5(18200) PMR値;δD2O ppm (D2Oを4.80として) 2.08(3H,s)、3.08(1H,dd,J=
18Hz,9Hz)、3.45(1H,dd,J=
18Hz,10Hz)、 4.29(2H,s)、5.0(1H,m)、7.42(1H,
t,J=5Hz)、8.70(2H,d,J=
5Hz) 実施例 16 (5R)p−ニトロベンジル6(E)−〔1−メチ
ル−2−(p−ニトロベンジル)オキシカルボニ
ルオキシエチリデン〕−1−アザビシクロ
〔3.2.0〕ヘプタ−3,7−ジオン−2−カルボキ
シレートの製造 (a) 4(R)1−(t−ブチルジメチルシリル)−
3(E)−〔1−メチル−2−(p−ニトロベンジ
ル)オキシカルボニルオキシエチリデン〕−4−
(2−t−ブチルジメチルシリルオキシエチル)−
アゼチジン−2−オンの製造 実施例12(a)で得られたE−アルコール体309mg
を塩化メチレン5mlに溶解し、窒素雰囲気下に0
℃に冷却して4−ジメチルアミノピリジン142mg
を加え、次いで塩化ギ酸p−ニトロベンジルエス
テル250mgを塩化メチレン2mlに溶解して加えて
氷冷下6時間撹拌した。途中3.5時間及び5時間
経過した時に、それぞれ上記と同量の4−ジメチ
ルアミノピリジン及び塩化ギ酸p−ニトロベンジ
ルエステルの塩化メチレン溶液を加えた。反応液
に塩化メチレンを加え、水洗・乾燥後濃縮する
と、黄色油状物1.0gが得られた。これをシリカ
ゲルカラムクロマトグラフイー〔溶媒;酢酸エチ
ル−n−ヘキサン(2:5)〕で精製すると黄色
油状物として目的物390mg(収率87.2%)が得ら
れた。 IR値;νCHCl3 nax cm-1 1750,1735,1610,1530 PMR値;δCDCl3 ppm 0.03(6H,s)、0.22(3H,s)、 0.25(3H,s)、0.84(9H,s)、 0.98(9H,s)、1.81〜2.13(2H,m)、 2.05(3H,s)、3.68(2H,t,J=
6Hz)、 4.32(1H,t,J=4Hz)、4.62(2H,
s)、 5.24(2H,s)、7.50(2H,d,J=
9Hz)、 8.19(2H,d,J=9Hz) (b) (4R)3(E)−〔1−メチル−2−(p−ニ
トロベンジル)オキシカルボニルオキシエチリデ
ン〕−4−(2−ヒドロキシエチル)−アゼチジン
−2−オンの製造 実施例16(a)で得られたジシリル化合物390mgを
90%メタノール水に溶解し、氷冷下濃塩酸0.24ml
を滴下し、氷冷下で2時間、次いで水冷下で15時
間撹拌した。反応液に飽和炭酸水素ナトリウム水
溶液を加えてPHを7に調整して濃縮したのち、残
渣を酢酸エチルに溶解し、乾燥後濃縮した。残渣
をシリカゲルカラムクロマトグラフイー〔溶媒;
クロロホルム−メタノール(7:1)〕で精製す
ると、無色結晶として目的物220mg(収率93.2%)
が得られた。 IR値;νKBr nax cm-1 3400(ブロード),1750,1710, 1610,1540 PMR値;δ CDCl3−CD3OD(6:1) ppm 1.59〜2.21(2H,m)、2.05(3H,s)、 3.68(2H,t,J=6Hz)、4.05(2H,
s)、 4.26(1H,dd,J=9Hz,4Hz)、4.63
(2H,s)、5.25(2H,s)、7.52(2H,
d,J=9Hz)、8.20(2H,d,J=
9Hz) (c) (4R)3(E)−〔1−メチル−2−(p−ニ
トロベンジル)オキシカルボニルオキシエチリデ
ン〕−4−カルボキシメチル−アゼチジン−2−
オンの製造 実施例16(b)で得られたアルコール体220mgをピ
リジン3mlに溶解し、これに無水クロム酸490mg
をピリジン6mlに溶解したものを加えて室温で
14.5時間撹拌した。反応液に水10mlを加え、酢酸
エチルで抽出して、抽出液を乾燥後濃縮すると褐
色油状物として、粗製の目的物276mgが得られた。 IR値;νFilm nax cm-1 3240,1750,1600,1520 (d) (4R)3(E)−〔1−メチル−2−(p−ニ
トロベンジル)オキシカルボニルオキシエチリデ
ン〕−4−〔3−(p−ニトロベンジル)オキシカ
ルボニル−2−オキソプロピル〕−アゼチジン−
2−オンの製造 実施例12(c)で得られた粗カルボン酸体276mgを
無水テトラヒドロフラン4.8mlに溶解し、窒素雰
囲気下に室温でN,N′−カルボニルジイミダゾ
ール112mgを加えて室温で2時間撹拌した。 一方、マロン酸モノp−ニトロベンジルエステ
ル245mgを無水テトラヒドロフラン3.8mlに溶解
し、窒素雰囲気下マグネシウムメトキシド88.3mg
を加え、室温で1時間撹拌した。これを濃縮し、
この残渣に上記のイミダゾライド溶液を加え、室
温で12時間撹拌した。反応液を濃縮し、残渣に酢
酸エチルと0.3規定塩酸の混液を加え、酢酸エチ
ルで抽出した。抽出液を飽和炭酸水素ナトリウム
水溶液で洗浄したのち乾燥すると褐色油状物が得
られた。これをシリカゲルカラムクロマトグラフ
イー〔溶媒;クロロホルム−メタノール(10:
1)〕で精製すると、無色結晶として目的物175mg
(収率前記(c)より51.5%)が得られた。 IR値;νFilm nax cm-1 3360(ブロード)、1740 PMR値;δCDCl3 ppm 2.10(3H,s)、2.83(1H,dd,J=
18Hz,9Hz)、3.32(1H,dd,J=
18Hz,2Hz)、3.50(2H,s)、 4.40(1H,m)、4.55(1H,s)、 4.63(1H,s)、5.22(4H,s)、 6.50(1H,s)、7.47(4H,d,J=
9Hz)、 8.15(4H,d,J=9Hz) (e) (4R)3(E)−〔1−メチル−2−(p−ニ
トロベンジル)オキシカルボニルオキシエチリデ
ン〕−4−〔3−(p−ニトロベンジル)オキシカ
ルボニル−2−オキソ−3−ジアゾプロピル〕−
アゼチジン−2−オンの製造 実施例16(d)で得られたβ−ケトエステル体175
mgをアセトニトリル5.8mlに溶解し、氷冷下にア
ジ化p−トルエンスルホニル0.058ml及びトリエ
チルアミン0.130mlを加え、室温で130分間撹拌し
た。反応液を濃縮し、残渣をシリカゲルカラムク
ロマトグラフイー〔溶媒;酢酸エチル−n−ヘキ
サン(1:1)〕で精製すると、黄色油状物とし
て目的物176mg(収率96.0%)が得られた。 IR値;νFilm nax cm-1 3160(ブロード)、2130、1740、 1645、1605、1520 PMR値;δCDCl3 ppm 2.04(3H,s)、3.02(1H,dd,J=
18Hz,9Hz)、3.58(1H,dd,J=
18Hz,3Hz)、4.48(1H,m)、4.62
(2H,s)、 5.22(2H,s)、5.30(2H,s)、 6.68(1H,ブロードs)、7.47(4H,d,
J=9Hz)、8.16(4H,d,J=9Hz) (f) (5R)p−ニトロベンジル6(E)−〔1−メ
チル−2−(p−ニトロベンジル)オキシカルボ
ニルオキシエチリデン〕−1−アザビシクロ
〔3.2.0〕ヘプタ−3,7−ジオン−2−カルボキ
シレートの製造 実施例16(e)で得られたジアゾ体176mgを脱気し
た無水ベンゼン9.5mlに溶解し、酢酸ロジウム0.3
mgを加えて窒素雰囲気下浴温78℃で90分間撹拌し
た。 反応液を過し、濃縮すると、黄色油状物とし
て目的物165mg(収率98.6%)が得られた。 IR値;νFilm nax cm-1 1750,1605,1520 PMR値;δCDCl3 ppm 2.08(3H,s)、2.44(1H,dd,J=
18Hz,7Hz)、2.82(1H,dd,J=
18Hz,7Hz)、4.62(1H,t,J=
7Hz)、4.70(2H,s)、4.74(1H,s)、
5.24(4H,s)、 7.50(4H,d,J=9Hz)、8.18(4H,
d,J=9Hz) 実施例 17 (5R)p−ニトロベンジル6(z及びE)−〔1
−メチル−2−(p−ニトロベンジル)オキシカ
ルボニルオキシエチリデン〕−3−(2−ピロリミ
ジニルチオ)−1−アザビシクロ〔3.2.0〕ヘプト
−2−エン−7−オン−2−カルボキシレートの
製造 実施例16で得られたビシクロケトン体74.0mgを
アセトニトリル5.36ml及びジメチルホルムアミド
0.4mlの混液に溶解し、窒素雰囲気下、氷冷下に
ジイソプロピルエチルアミン0.028mlを加え、次
いで塩化ジフエニルリン酸0.031mlをアセトニト
リル0.1mlに溶解した溶液を0℃に冷却して加え
て、氷冷下に10分間撹拌した。反応液を−25℃に
冷却し、ジイソプロピルエチルアミン0.102ml及
び2−メルカプトピリミジン16.9mgを加え、0℃
で30分間撹拌したのち、冷蔵庫中に17時間放置し
た。反応液に酢酸エチルを加え、飽和食塩水で洗
浄したのち乾燥して濃縮した。残渣をシリカゲル
カラムクロマトグラフイー〔溶媒;クロロホルム
−メタノール(30:1)〕で精製したのち、更に
シリカゲルカラムクロマトグラフイー〔溶媒;酢
酸エチル−n−ヘキサン(3:1)〕で分離する
と、淡黄色油状物として、目的のE体38.9mg(収
率44.8%)及びZ体10.4mg(収率14.2%)が得ら
れた。これらは何れも、その物理化学的性状が実
施例13で得られた化合物と一致した。 実施例 18 (5R)p−ニトロベンジル6(E及びz)−〔1
−メチル−2−(p−ニトロベンジル)オキシカ
ルボニルオキシエチリデン〕−3−〔2−(p−ニ
トロベンジルオキシカルボニル)アミノエチルチ
オ〕−1−アザビシクロ〔3.2.0〕ヘプト−2−エ
ン−7−オン−2−カルボキシレートの製造 実施例16で得られたビシクロケトン体138mgを
アセトニトリル10mlとジメチルホルムアミド0.5
mlの混液に溶解し、窒素雰囲気下、0℃に冷却し
て撹拌した。これにジイソプロピルエチルアミン
38mgを加え1分間撹拌したのち、塩化リン酸ジフ
エニル75.65mgをアセトニトリル1.83mlに溶解し
た溶液を0℃に冷却して加え、10分間撹拌した。
反応液を−25℃に冷却してジイソプロピルエチル
アミン140mgを添加し、直ちにN−p−ニトロベ
ンジルオキシカルボニルシステアミン72.09mgを
アセトニトリル4.6mlに溶解して加え、0℃で30
分間撹拌したのち、冷蔵庫中に15時間放置した。
反応液に酢酸エチルを加えたのち水洗し、乾燥後
濃縮すると、褐色の油状物300mgが得られた。こ
れをシリカゲルのカラムに付し、クロロホルム−
メタノール(20:1)で溶出し、次いでn−ヘキ
サン−酢酸エチル(2:1)で分離すると、黄色
油状物として目的の(E)体58mg(収率29.2%)
及び(Z)体27mg(収率13.6%)が得られた。 (E)体 比旋光度:〔α〕22 D +20.0゜(c2.9,THF) IR値:νCHCl3 nax cm-1 1755,1715,1520 UV値:λTHF nax nm(ε) 249(24100),262(34600) PMR値;δCDCl3 ppm 2.07(3H,s)、2.8〜3.6(6H,コンプレ
ツクスm) 4.6〜4.96(3H,コンプレツクスm) 5.0〜5.65(7H,コンプレツクスm) 7.42(2H,d,J=8Hz)、7.51(2H,
d,J=8Hz)、7.63(2H,d,J=
8Hz)、 8.15(2H,d,J=8Hz)、8.17(2H,
d,J=8Hz)、8.20(2H,d,J=
8Hz) (Z)体 比旋光度:〔α〕22 D −16.3゜(c1.35,THF) IR値:νCHCl3 nax cm-1 1760,1750(シヨルダー) 1715,1520 PMR値:δCDCl3 ppm 1.86(3H,s)、2.70〜3.60(6H,コンプ
レツクスm)、4.72(1H,dd,J=8Hz,
10Hz)、5.04(2H,ブロードs)、5.08〜
5.60(6H,コンプレツクスm)、7.25
(2H,d,J=8Hz)、7.32(2H,d,J
=8Hz)、7.42(2H,d,J=8Hz)、
8.04〜8.35(6H,コンプレツクスm) 実施例 19 (5R)p−ニトロベンジル6(E及びz)−〔1
−メチル−2−(p−ニトロベンジル)オキシカ
ルボニルオキシエチリデン〕−3−エチルチオ−
1−アザビシクロ〔3.2.0〕ヘプト−2−エン−
7−オン−2−カルボキシレートの製造 実施例16で得られたビシクロケトン体152mg及
びエチルメルカプタン19.26mgを用いて実施例18
と同様に反応処理し、n−ヘキサン−酢酸エチル
(1:1)を用いるシリカゲルクロマトグラフイ
ー、次いでクロロホルム−メタノール(50:1)
を用いるシリカゲルクロマトグラフイーで分離、
精製すると、目的の(E)体48mg(収率29.2%)
及び(Z)体7mg(収率4.3%)が各々黄色油状
物として得られた。 (E)体 IR値:νCHCl3 nax cm-1 1765、1730(シヨルダー)、1525 PMR値:δCDCl3 ppm 1.18(3H,t,J=6Hz)、2.07(3H,
s)、3.05〜3.90(4H,コンプレツクス
m)、 4.50〜4.90(3H,コンプレツクスm)、 5.19(1H,d,J=14Hz)、5.20(2H,
s)、5.41(1H,d,J=14Hz)、7.45
(2H,d,J=8Hz)、7.54(2H,d,J
=14Hz)、8.12(2H,d,J=8Hz)、 8.14(2H,d,J=8Hz) (Z)体 PMR値:δCDCl3 ppm 1.19(3H,t,J=6Hz)、1.85(3H,
s)、3.0〜3.8(4H,コンプレツクスm)、 4.5〜4.9(1H,m)、5.04(2H,ブロード
s)、 5.20(1H,d,J=14Hz)、5.24(2H,
s)、5.50(1H,d,J=14Hz)、7.52
(2H,d,J=8Hz)、7.63(2H,d,J
=8Hz)、8.17(2H,d,J=8Hz)、 8.20(2H,d,J=8Hz) 実施例 20 (5R)p−ニトロベンジル6(E及びz)−〔1
−メチル−2−(p−ニトロベンジル)オキシカ
ルボニルオキシエチリデン〕−3−(2−ピリジル
チオ)−1−アザビシクロ〔3.2.0〕ヘプト−2−
エン−7−オン−2−カルボキシレートの製造 実施例16で得られたビシクロケトン体142mg及
び2−メルカプトピリジン32.2mgを用い実施例18
と同様に反応処理し、シリカゲルカラムクロマト
グラフイー〔溶媒:n−ヘキサン−酢酸エチル
(2:5)〕で分離精製すると、目的の(E)体
73.6mg(収率44.2%)及び(Z)体5.1mg(収率
3.1%)が各々黄色油状物として得られた。 (E)体 比旋光度:〔α〕22.5 D −30゜(c1,THF) IR値:νCHCl3 nax cm-1 2940、1760、1710、1610、1560 UV値:λTHF nax nm(ε) 285(15600)、262(23900) PMR値:δCDCl3 ppm 2.08(3H,s)、3.03(1H,dd,J=
18Hz,8Hz)、3.33(1H,dd,J=
18Hz,10Hz)、4.68(2H,ブロードs)、 4.84(1H,m)、5.19(2H,s)、5.28
(1H,d,J=14Hz)、5.56(1H,d,
J=14Hz)、7.20(1H,m)、7.36〜7.64
(4H,コンプレツクスm)、7.69(2H,
d,J=8Hz)、8.24(4H,d,J=
8Hz)、8.49(1H,dd,J=5Hz,2Hz) (Z)体 IR値:νCHCl3 nax cm-1 2910,1750,1605,1570,1560 PMR値:δCDCl3 ppm(主要ピーク) 1.79(3H,s)、5.06(2H,s)、5.25
(1H,d,J=14Hz)、5.28(2H,s)、 5.43(1H,d,J=14Hz)、7.0〜7.3
(1H,m)、7.4〜7.8(6H,コンプレツク
スm)、8.24(4H,d,J=8Hz)、8.48
(1H,m) 実施例 21 (5R)p−ニトロベンジル6(E及びz)−〔1
−メチル−2−(p−ニトロベンジル)オキシカ
ルボニルオキシエチリデン〕−3−(4,6−ジメ
チル−2−ピリミジニルチオ)−1−アザビシク
ロ〔3.2.0〕ヘプト−2−エン−7−オン−2−
カルボキシレートの製造 実施例16で得られたビシクロケトン体119mg及
び4,6−ジメチル−2−メルカプトピリミジン
34mgを用い、実施例18と同様に反応処理し、n−
ヘキサン−酢酸エチル(1:2)次いでクロロホ
ルム−メタノール(20:1)を溶媒として用いる
シリカゲルクロマトグラフイーで分離精製する
と、目的の(E)体60mg(収率41.2%)及び
(Z)体10mg(収率6.9%)が各々淡黄色粉末とし
て得られた。 (E)体 IR値:νCHCl3 nax cm-1 1760,1715(シヨルダー),1560, 1525 PMR値:δCDCl3 ppm 2.10(3H,s)、2.35(6H,s)、3.20
(1H,dd,J=18Hz,10Hz)、3.86
(1H,dd,J=18Hz,10Hz)、4.70
(2H,ブロードs)、4.87(1H,dd,J
=10Hz,8Hz)、5.22(2H,s)、 5.26(1H,d,J=14Hz)、5.50(1H,
d,J=14Hz)、6.73(1H,s)、7.45
(2H,d,J=8Hz)、7.64(2H,d,J
=8Hz)、8.14(2H,d,J=8Hz)、
8.18(2H,d,J=8Hz) (Z)体 IR値:νCHCl3 nax cm-1 1765,1715(シヨルダー),1590, 1530 PMR値:δCDCl3 ppm 1.85(3H,s)、2.41(6H,s)、3.15
(1H,dd,J=18Hz,8Hz)、3.92(1H,
dd,J=18Hz,10Hz)、 4.82(1H,dd,J=10Hz,8Hz)、5.06
(2H,s)、5.24(1H,d,J=14Hz)、 5.26(2H,s)、5.52(1H,d,J=
14Hz)、 6.80(1H,s)、7.53(2H,d,J=
8Hz)、 7.65(2H,d,J=8Hz)、8.20(4H,ブ
ロードd,J=8Hz) 実施例 22 (5R)6(E)−(1−メチル−2−ヒドロキシ
エチリデン)−3−(2−ピリジルチオ)−1−ア
ザビシクロ〔3.2.0〕ヘプト−2−エン−7−オ
ン−2−カルボン酸の製造 実施例20で得られたp−ニトロベンジルエステ
ル体〔(E)体〕57mgをジオキサン2.4mlとPH7.0
のリン酸緩衝液1.4mlの混液に溶解し、5%パラ
ジウム炭素57mgを加えて、水素(1気圧)雰囲気
下に2時間撹拌した。これを実施例7と同様に処
理、精製すると淡黄色粉末の目的物5.7mg(収率
19.9%)が得られた。 比旋光度:〔α〕25 D −115゜(c0.3,水) IR値:νKBr nax cm-1 1760,1730,1600,1575 UV値:λPBS nax(PH7.0) nm(ε) 290.5(6620)、238(14100) PMR値:δD2O ppm(重水を4.80として) 2.11(3H,s)、2.98(2H,d,J=
10Hz)、 4.28(2H,s)、5.10(1H,m)、7.56
(1H,dd,J=6Hz,4Hz)、7.76(1H,
d,J=8Hz)、7.89(1H,m)、 8.62(1H,ブロードs,J=4Hz) 実施例 23 (5R)6(E)−(1−メチル−2−ヒドロキシ
エチリデン)−3−(4,6−ジメチル−2−ピリ
ミジルチオ)−1−アザビシクロ〔3.2.0〕ヘプト
−2−エン−7−オン−2−カルボン酸の製造 実施例21で得られたp−ニトロベンジルエステ
ル体〔(E)体〕60mgをジオキサン2.54mlとPH7.0
のリン酸緩衝液1.6mlの混液に溶解し、5%パラ
ジウム炭素60mgを加えて、水素(1気圧)雰囲気
下に2時間撹拌した。これを実施例7と同様に処
理、精製すると、淡黄色粉末の目的物24.7mg(収
率78.5%)が得られた。 比旋光度:〔α〕29 D −145.2゜(c0.785、水) IR値:νKBr nax cm-1 1745,1620(シヨルダー)、1590 UV値:λPBS nax(PH7.0) nm(ε) 282(6850)、239(13470) PMR値:δD2O ppm(重水を4.80として) 2.08(3H,s)、2.51(6H,s)、2.98
(1H,dd,J=17Hz,9Hz)、3.48(1H,
dd,J=17Hz,10Hz)、4.30(2H,
s)、5.06(1H,dd,J=10Hz,9Hz)、
7.16(1H,s)。
[Formula] Dissolve 1.124 g of the disilyl compound obtained in Example 1(d) (approximately 3:1 mixture of 3-isopropylidene compound and 3-trimethylsilyl compound) in 31.25 ml of methanol-water (9:1) mixture. The mixture was cooled to 0°C and stirred, 1.03 ml of concentrated hydrochloric acid was added, and the mixture was stirred at 0°C for 1.5 hours. The reaction solution was neutralized with a saturated aqueous sodium hydrogen carbonate solution, and methanol was distilled off. The residue was extracted with ethyl acetate, and the extract was dried and concentrated. The residue was purified by silica gel column chromatography (solvent: ethyl acetate) to obtain 342 mg of the target product as colorless crystals (75.4% yield for Examples 1(d) and 1(e)). IR value: ν CHCl3 nax cm -1 3440, 1730 PMR value: δ CDCl3 ppm 1.72 (3H, s), 2.02 (3H, s), 1.5 to 2.3 (2H, complex m) 3.77 (2H, t, J= 6Hz) 4.20 (1H, dd, J = 9Hz, 2Hz) (f) Production of (4R)-3-isopropylidene-4-carboxymethyl-azetidin-2-one 66 mg of the alcohol obtained in Example 1(e) was dissolved in 0.4 ml of pyridine, and 180 mg of chromic acid was dissolved in pyridine.
3.9 ml of the solution was added and stirred at room temperature for 19 hours. The reaction solution was extracted with ethyl acetate, and the extract was diluted with saturated brine.
After washing with sodium bisulfite, drying and concentration gave a pale yellow oil. This oil was dissolved in ethyl acetate, extracted with saturated aqueous sodium bicarbonate solution, and washed with ethyl acetate. extract liquid
After acidifying with 2N hydrochloric acid, extracting with ethyl acetate,
After drying and concentration, 52 mg (yield 72.3%) of the target product was obtained as pale yellow crystals. IR value: ν CHCl3 nax cm -1 3430, 1725, 1715 PMR value: δ CDCl3 ppm 1.72 (3H, s), 2.00 (3H, s), 2.48 (1H, dd, J=17Hz, 10Hz), 2.90 (1H , dd, J = 17Hz, 3Hz), 4.35 (1H, dd, J = 10Hz, 3Hz), 7.50 (1H, br, s), 9.24 (1H, br, s) (g) (4R)-3-isopropylene Ridden-4-[3-
(p-nitrobenzyl)oxycarbonyl-2-
Production of [oxopropyl]-azetidin-2-one 418 mg of the carboxylic acid obtained in Example 1(f) was dissolved in 15.2 ml of tetrahydrofuran, 441.5 mg of N,N'-carbonyldiimidazole was added under a nitrogen atmosphere, and the mixture was stirred for 1 hour and 50 minutes. On the other hand, 845 mg of mono-p-nitrobenzyl malonate
was dissolved in 9 ml of anhydrous tetrahydrofuran and added with magnesium methoxide while stirring under nitrogen atmosphere.
152.6 mg was added and stirred for 1 hour. The solvent was distilled off from the reaction solution under reduced pressure, and the previously synthesized imidazolide solution was added to this residue, followed by stirring at room temperature for 20 hours. Concentrate the reaction solution and dissolve the residue in ethyl acetate-0.3N
After extraction with hydrochloric acid (5:1), the extract was washed with an aqueous sodium bicarbonate solution, dried, and concentrated to obtain a brown oil. When this was purified by silica gel column chromatography (solvent: ethyl acetate), 798 mg of the desired product was obtained as a pale yellow oil (yield:
93.2%) was obtained. IR value: ν CHCl3 nax cm -1 3440, 1745, 1720 (shoulder) PMR value: δ CDCl3 ppm 1.70 (3H, s), 2.04 (3H, s), 2.75 (1H, dd, J = 18Hz, 10Hz), 3.16 (1H, dd, J=18Hz, 3Hz), 3.58 (2H, s), 4.38 (1H, dd, J=10Hz,
3Hz), 5.26 (2H, s), 6.30 (1H, br, s), 7.52 (2H, d, J = 8Hz), 8.22 (2H, d, J
=8Hz) (h) (4R)-3-isopropylidene-4-[3-
(p-nitrobenzyl)oxycarbonyl-2-
Oxo-3-diazopropyl]-azetidine-2
- Manufacture of on 758 mg of the ketoester obtained in Example 1 (g) and 587 mg of p-toluenesulfonyl azide were dissolved in 30 ml of acetonitrile, cooled to 0°C, and 800 mg of triethylamine was added with stirring, and the mixture was dissolved at room temperature for 30 min.
Stir for a minute. The reaction solution was concentrated and the residue was purified by silica gel thin layer chromatography [solvent: n-hexane-ethyl acetate (1:1)] to obtain 572 mg (yield 70.2%) of the target product as a pale yellow semi-solid. Ta. IR value: ν CHCl3 nax cm -1 3440, 2130, 1725 (broad) PMR value: δ CDCl3 ppm 1.72 (3H, s), 2.01 (3H, s) 2.90 (1H, dd, J=18Hz, 10Hz) 3.50 ( 1H, dd, J = 18Hz, 3Hz) 4.36 (1H, dd, J = 9Hz, 3Hz), 5.34 (2H,
s) 6.48 (1H, br, s), 7.50 (2H, d, J=
8Hz) 8.20 (2H, d, J = 8Hz) (i) (5R) p-Nitrobenzyl 6-isopropylidene-1-azabicyclo[3.2.0]heptane-
Production of 3,7-dione-2-carboxylate 46 ml of degassed anhydrous benzene was added to 572 mg of the diazo compound obtained in Example 1(h) and 1.7 mg of rhodium acetate, and the mixture was heated under a nitrogen atmosphere at a bath temperature of 78° C. for 1 hour.
After cooling, insoluble matter was removed and the liquid was concentrated to obtain 537 mg (quantitative) of the target product in the form of light brown crystals. IR value: ν CHCl3 nax cm -1 1750 PMR value: δ CDCl3 ppm 1.81 (3H, s), 2.09 (3H, s) 2.40 (1H, dd, J=19Hz, 7Hz), 2.87 (1H, dd, J= 19Hz, 7Hz), 4.56 (1H, t, J = 7Hz), 4.67 (1H, s) 5.20 (1H, d, J = 14Hz), 5.36 (1H, d,
J = 14Hz), 7.51 (2H, d, J = 8Hz) 8.17 (2H, d, J
=8Hz) Example 2 (5R) p-nitrobenzyl 6-isopropylidene-3-(2-acetylaminoethylthio)-1
-Azabicyclo[3.2.0]hept-2-ene-7
-Production of -one-2-carboxylate The bicycloketone obtained in Example 1, namely (5R) p-nitrobenzyl 6-isopropylidene-1-azabicyclo[3.2.0]heptane-3,7
-Dissolve 100 mg of dione-2-carboxylate in 5.8 ml of acetonitrile, cool to 0°C, add 4 mg of 4-dimethylaminopyridine and 0.063 ml of diisopropylethylamine with stirring, react for 1 minute, and then 93.3 mg of diphenyl chloride phosphate. A solution of 1 ml of acetonitrile was added after cooling to 0°C.
After reacting for 10 minutes, it was cooled to -25℃, 0.215ml of diisopropylethylamine was added, and immediately N
- 76.4 mg of acetylcysteamine dissolved in 2 ml of acetonitrile was added, reacted at 0°C for 1 hour, and left in the refrigerator for 17 hours. Ethyl acetate was added to the reaction solution, washed with water, dried, and concentrated to obtain a red oil. This was purified by silica gel column chromatography [solvent: methylene chloride-methanol (20:1)] to obtain 85 mg (yield 65.7%) of the desired product as pale yellow crystals. Specific optical rotation: [α] 24 D −10.0° (c1.0, THF) IR value: ν CHCl3 nax cm -1 3470, 1765, 1700, 1670 UV value: λ THF nax nm 297 (ε=11320), 289 (ε=11680) 267 (ε=12990), 244 (ε=13940) PMR value: δ CDCl3 ppm 1.82 (3H, s), 1.95 (3H, s) 2.10 (3H, s), 2.7-3.6 (6H, Complex m) 4.72 (1H, t, J = 9Hz), 5.21 (1H, d, J
= 14Hz) 5.52 (1H, d, J = 14Hz), 6.04 (1H, br,
s) 7.66 (2H, d, J = 9Hz), 8.20 (2H, d, J
=9Hz) Example 3 (5R) p-Nitrobenzyl 6-isopropylidene-3-(2-hydroxyethylthio)-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylate Manufacturing of Using 131 mg of the bicycloketone obtained in Example 1 and 69.8 mg of 2-mercaptoethanol, the reaction treatment was carried out in the same manner as in Example 2, and when purified by silica gel column chromatography (solvent: ethyl acetate), colorless crystals were obtained. Target product 51mg (yield 33.2
%)was gotten. Specific optical rotation; [α] 22 D +9.0゜ (c1.0, THF) IR value: ν CHCl3 nax cm -1 3500 (broad), 1765, 1700 UV value: λ THF nax nm 300 (ε=10530) , 266 (ε=10810) 244 (ε=12540) PMR value; δ CDCl3 ppm 1.80 (3H, s), 2.00 (1H, br.) 2.09 (3H, s), 2.8 to 3.6 (4H, complex m) 3.72-4.00 (2H, complex m), 4.68 (1H, t, J = 8Hz), 5.20 (1H, d, J
= 14Hz) 5.50 (1H, d, J = 14Hz), 7.64 (2H, d,
J=8Hz) 8.18 (2H, d, J=8Hz) Example 4 (5R) p-Nitrobenzyl 6-isopropylidene-3-phenylthio-1-azabicyclo[3.2.0]hept-2-en-7-one -Production of 2-carboxylate Using 110 mg of the bicycloketone compound obtained in Example 1 and 82.6 mg of thiophenol, the reaction and treatment were carried out in the same manner as in Example 2, and silica gel column chromatography [solvent: methylene chloride-ethyl acetate (10:1)] When purified, 19 mg (yield 13.6%) of the desired product was obtained as a pale yellow powder. Specific optical rotation; [α] 22 D −92.6° (c0.95, THF) IR value; ν CHCl3 nax cm -1 1760, 1700 UV value; λ THF nax nm 331 (ε=7490), 289 (ε=11930 ) 266 (ε=13090), 254 (ε=14280) PMR value; δ CDCl3 ppm 1.68 (3H, s), 2.06 (3H, s) 2.63 (2H, d, J=9Hz), 4.54 (1H, t, J
= 8Hz) 5.25 (1H, d, J = 14Hz), 5.56 (1H, d,
J=14Hz) 7.2-7.7 (5H, m), 7.68 (2H, d, J=8Hz) 8.19 (2H, d, J=8Hz) Example 5 (5R) p-Nitrobenzyl 6-isopropylidene-3- (2-pyrimidinylthio)-1-azabicyclo[3.2.0]hept-2-en-7-one-
Production of 2-carboxylate Using 100 mg of the bicycloketone compound obtained in Example 1 and 71.8 mg of 2-mercaptopyrimidine, the reaction and treatment were carried out in the same manner as in Example 2, and when purified by silica gel column chromatography (solvent: ether), pale yellow crystals were obtained. 75 mg of the target product (yield 58.9
%)was gotten. Specific optical rotation: [α] 24 D −79.5° (c1.9, THF) IR value: ν CHCl3 nax cm -1 1770, 1705 UV value: λ THF nax nm 330 (ε=12640), 321 (ε=13500 ) 290 (ε=17400), 247 (ε=25100) PMR value: δ CDCl3 ppm 1.80 (3H, s), 2.11 (3H, s) 3.10 (1H, dd, J=18Hz, 8Hz) 3.86 (1H, dd , J=18Hz, 11Hz) 4.80 (1H, m), 5.28 (1H, d, J=14Hz) 5.52 (1H, d, J=14Hz), 7.07 (1H, t,
J = 4Hz) 7.66 (2H, d, J = 9Hz), 8.19 (2H, d, J
= 9Hz) 8.54 (2H, d, J = 4Hz) Example 6 (5R) p-Nitrobenzyl 6-isopropylidene-3-(2-pyridylthio)-1-azabicyclo[3.2.0]hept-2-ene- 7-on-2-
Production of carboxylates Using 120 mg of the bicycloketone compound obtained in Example 1 and 91.2 mg of 2-mercaptopyrimidine, the reaction and treatment were carried out in the same manner as in Example 2, and when purified by silica gel column chromatography (solvent: ether), yellow crystals were obtained. Target product 83mg (yield 54.3
%)was gotten. Specific optical rotation; [α] 24 D −71.1° (c4.15, THF) IR value; ν CHCl3 nax cm -1 1770, 1700 UV value; λ THF nax nm 289 (ε=14050), 262.5 (ε=16600 ) 246 (ε=18600) PMR value; δ CDCl3 ppm 1.74 (3H, s), 2.05 (3H, s) 2.90 (1H, dd, J=18Hz, 8Hz) 3.29 (1H, dd, J=18Hz, 10Hz) 4.69 (1H, dd, J = 10Hz, 8Hz) 5.30 (1H, d, J = 14Hz), 5.56 (1H, d,
J = 14Hz) 6.9 to 7.3 (1H, m) 7.35 to 7.8 (2H, complex m) 7.69 (2H, d, J = 8Hz), 8.20 (2H, d, J
= 8Hz) 8.56 (1H, br, d, J = 4Hz) Example 7 (5R) 6-isopropylidene-3-(2-acetylaminoethylthio)-1-azabicyclo[3.2.0]hept-2-ene Production of -7-one-2-carboxylic acid sodium salt 85 mg of p-nitrobenzyl ester obtained in Example 2 was dissolved in a mixture of 6 ml of dioxane and 3.1 ml of 0.1 M phosphate buffer with pH 7.6, 90 mg of 5% palladium on carbon was added, and hydrogen (1 atm) was added. The mixture was stirred under atmosphere for 3 hours. After removing the catalyst from the reaction solution and washing the solution with ethyl acetate, common salt was added to the aqueous layer to give a concentration of 5%. Add this to Diamondion HP-20 (25
ml) column, washed with water and eluted with 30% methanol water, and fractions containing the target product were collected. This was concentrated and then freeze-dried to obtain 25.9 mg (yield 40.8%) of the desired sodium salt as a pale yellow powder. Specific optical rotation; [α] 24 D −26.1° (c0.88, H 2 O) IR value; ν KBr nax cm -1 1770, 1650, 1600 UV value; λ PBS nax (PH7.0) nm (ε) 284 (5689), 238 (12710) PMR value; δ D2O ppm (with heavy water as 4.80) 1.93 (3H, s), 2.06 (3H, s) 2.13 (3H, s), 2.8 to 4.0 (6H, Combrex m) , 4.78 (1H, m) Example 8 (5R) 6-isopropylidene-3-(2-hydroxyethylthio)-1-azabicyclo[3.2.0]
Preparation of hept-2-en-7-one-2-carboxylic acid sodium salt. 51 mg of the p-nitrobenzyl ester compound obtained in Example 3 was mixed with 2.66 ml of dioxane at a pH of 7.2.
Dissolved in 1.86ml of 0.1M phosphate buffer, 5%
54 mg of palladium on carbon was added, and the mixture was stirred for 2 hours under a hydrogen (1 atm) atmosphere. When this was treated and purified in the same manner as in Example 7, sodium salt was obtained as a colorless powder.
8.5 mg (yield 23.2%) was obtained. Specific optical rotation; [α] 22 D +6.89° (c0.145, H 2 O) IR value; ν KBr nax cm -1 1770, 1600 (broad) UV value; λ PBS nax (PH7.0) nm ( ε) 285 (6740), 239 (14470) PMR value; δ D2O (with heavy water as 4.80) ppm 1.97 (3H, s), 2.14 (3H, s) 2.95-3.40 (4H, complex m),
3.84 (2H, t, J=6Hz), 4.72 (1H,
m) Example 9 (5R) 6-isopropylidene-3-phenylthio-1-azabicyclo[3.2.0]hept-2-
Production of en-7-one-2-carboxylic acid sodium salt 19 mg of the p-nitrobenzyl ester obtained in Example 4 was dissolved in a mixture of 0.7 ml of dioxane and 0.7 ml of 0.1 M phosphate buffer at pH 7.2, 20 mg of 5% palladium on carbon was added, and hydrogen (1 atm) was added. Stirred under atmosphere for 2 hours. The solvent was removed from the reaction solution, and the solution was washed with ethyl acetate to obtain 25 ml of an aqueous solution of the desired sodium salt (OD of 7-fold dilution: 0.672). UV value; λPBS (PH7.2) max nm 280 Example 10 (5R)6-isopropylidene-3-(2-pyrimidinylthio)-1-azabicyclo[3.2.0]hept-2-en-7-one- Production of 2-carboxylic acid 67 mg of the p-nitrobenzyl ester obtained in Example 5 was dissolved in a mixture of 4.7 ml of dioxane and 4.7 ml of 0.1M phosphate buffer at pH 7.2, 70 mg of 5% palladium on carbon was added, and hydrogen (1 atm) was added. ) Stirred under atmosphere for 3 hours. When this was treated and purified in the same manner as in Example 7, the desired carboxylic acid 29.7 was obtained as a pale yellow powder.
mg (yield 64.0%) was obtained. Specific optical rotation; [α] 24 D −194° (c1, H 2 O) IR value; ν KBr nax cm -1 1760, 1700, 1560, 1540 UV value; λ PBS nax (PH7.0) nm (ε) 280 (11900), 243 (21300) PMR value; δ D2O ppm (with heavy water as 4.80) 1.87 (3H, s), 2.12 (3H, s) 2.93 (1H, dd, J=18Hz, 8Hz), 3.48
(1H, dd, J = 18Hz, 10Hz) 4.79 (1H, m), 7.39 (1H, t, J =
5Hz) 8.68 (2H, d, J = 5Hz) Example 11 (5R) 6-isopropylidene-3-(2-pyridylthio)-1-azabicyclo[3.2.0]hept-
Production of 2-en-7-one-2-carboxylic acid 83 mg of the p-nitrobenzyl ester obtained in Example 6 was dissolved in a mixture of 4 ml of dioxane and 2.4 ml of 0.1 M phosphate buffer at pH 7.2, 85 mg of 5% palladium on carbon was added, and hydrogen (1 atm) was added. The mixture was stirred under atmosphere for 3 hours. When this was treated and purified in the same manner as in Example 7, the desired carboxylic acid was obtained as a pale yellow powder.
16.3 mg (yield 28.4%) was obtained. Specific optical rotation; [α] 24 D −142.2° (c0.45, H 2 O) IR value; ν KBr nax cm -1 1740, 1602, 1575, 1560 UV value; λ PBS nax (PH7.0) nm ( ε) 291, 241 (15680) PMR value; δ D2O ppm (with heavy water as 4.80) 1.83 (3H, s), 2.14 (3H, s) 2.76 (1H, dd, J=17Hz, 8Hz), 3.01 (1H, dd, J=17Hz, 10Hz) 4.75 (1H, m), 7.49 (1H, dd, J=
6Hz, 4Hz), 7.68 (1H, d, J = 8Hz), 7.92 (1H, m), 8.56 (1H, br.d, J =
4Hz) Example 12 (5R)p-nitrobenzyl6(z)-[1-methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-1-azabicyclo[3.2.0]hepta-3,7- Production of dione-2-carboxylate (a) (4R) 1-(t-butyldimethylsilyl)-
3(Z and E)-(1-methyl-2-hydroxy)
Production of ethylidene-4-(2-t-butyldimethylsilyl)oxyethyl-azetidin-2-one The isopropylidene compound (3) obtained in Example 1(d)
- 984 mg of trimethylsilyl compound (containing about 25%) was dissolved in 20 ml of dioxane, and the bath temperature was 105°C.
A solution prepared by dissolving 218 mg of selenium dioxide in 12 ml of a mixture of dioxane and water (5:1) was added dropwise to the mixture while stirring, and the mixture was stirred for 41.5 hours. During the process, after 14 hours had passed, the same amount of selenium dioxide as above in dioxane-aqueous solution was added. After the reaction, insoluble matter was removed and the liquid was concentrated, and the residue was dissolved in ethyl acetate. After washing with water, washing with a saturated aqueous solution of sodium bicarbonate, drying and concentrating, 1.0g of yellow oil was obtained.
was gotten. Dissolve this oil in methanol,
40 mg of sodium borohydride was added under ice cooling, and the mixture was stirred for 70 minutes. Concentrate the reaction solution, dissolve the residue in ethyl acetate, wash with water, dry, and concentrate to form a brown oil.
1.0g was obtained. When this was purified by silica gel column chromatography [solvent: n-hexane-ethyl acetate (6:1)], the Z-form was obtained as a colorless oil.
270 mg (yield 35.3%) and 110 mg (yield 14.4)
%)was gotten. Z-body IR value; ν CHCl3 nax cm -1 3340 (broad), 1695 PMR value; δ CDCl3 ppm 0.04 (6H, s), 0.26 (3H, s) 0.30 (3H, s), 0.70 (9H, s) 0.98 (9H, s), 1.72 (3H, s) 1.60 to 2.06 (2H, complex m), 3.72 (2H, t, J=6Hz), 4.25 (3H, complex m) E body IR value; ν CHCl3 nax cm -1 1720 NMR value; δ CDCl3 ppm 0.06 (6H, s), 0.21 (3H, s) 0.25 (3H, s), 0.90 (9H, s) 0.97 (9H, s), 1.60~2.19 (2H, m), 2.02 (3H, s), 3.77 (2H, t, J=6Hz), 4.10 (2H,
s), 4.40 (1H, m) (b) (4R) 1-(t-butyldimethylsilyl)-
3(Z)-[1-methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-4-
(2-t-butyldimethylsilyloxyethyl)-
Production of azetidin-2-one 270 mg of Z-alcohol obtained in Example 12(a)
was dissolved in 3 ml of methylene chloride, cooled to 0°C, 0.113 ml of triethylamine and 8.3 mg of 4-dimethylaminopyridine were added, and then 175 mg of formic acid p-nitrobenzyl chloride dissolved in 1 ml of methylene chloride was added, and the mixture was cooled to 0°C. for 30 minutes, followed by stirring at room temperature for 22 hours. During 1 hour and 3 hours, the reaction solution was cooled to 0°C, and triethylamine, 4-
Dimethylaminopyridine and a methylene chloride solution of formic acid p-nitrobenzyl chloride were added in twice the above amount, and after 7 hours, the same amount as above was added. After the reaction was completed, methylene chloride was added to the reaction solution, washed with water, dried, and concentrated. The yellow solid residue was subjected to silica gel column chromatography [solvent: n
-hexane-ethyl acetate (10:1)] to obtain 267 mg (yield 68.3%) of the desired product as a colorless powder. IR value; ν CHCl3 nax cm -1 1730, 1610 PMR value; δ CDCl3 ppm 0.04 (6H, s), 0.24 (3H, s) 0.28 (3H, s), 0.85 (9H, s) 0.96 (9H, s) , 1.83 (3H, s) 1.60-2.06 (2H, complex m), 3.72 (2H, t, J=6Hz), 4.30 (1H,
t, J = 4Hz), 5.10 (2H, s), 5.24 (2H, s), 7.55 (2H, d, J =
9Hz), 8.18 (2H, d, J = 9Hz) (c) (4R)3(Z)-[1-methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-4-(2-hydroxyethyl )-Production of azetidin-2-one 267 mg of the disilyl compound obtained in Example 12(b) was dissolved in 10 ml of a mixture of methanol and water (9:1),
The mixture was cooled to 0° C., 0.165 ml of concentrated hydrochloric acid was added, and the mixture was stirred for 15 minutes, followed by stirring for 4 hours and 30 minutes under water cooling. After adjusting the reaction solution to pH 8 with a saturated aqueous solution of sodium hydrogen carbonate, methanol was distilled off, and the mixture was extracted with ethyl acetate. After drying the organic layer and concentrating it, the residue was washed with n-hexane to obtain the desired product as colorless crystals.
165 mg (quantitative) was obtained. PMR value; δ CDCl 3 −CD 3 OD (6:1) ppm 1.82 (3H, s), 1.60 to 2.15 (2H, complex m), 3.70 (2H, t, J=
6Hz), 4.25 (1H, dd, J=9Hz, 3Hz), 5.03
(2H, s), 5.29 (2H, s), 7.59 (2H,
d, J = 9Hz), 8.22 (2H, d, J =
9Hz) (d) (4R)3(Z)-[1-methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-4-carboxymethyl-azetidine-2-
on manufacturing 165 mg of the alcohol obtained in Example 12(c) was dissolved in 5 ml of pyridine, 483 mg of chromic acid dissolved in 7 ml of pyridine was added, and the mixture was stirred at room temperature for 14 hours. After adding 100 ml of water to the reaction solution, it was extracted with ethyl acetate, dried and concentrated, and the resulting residue was dissolved in ethyl acetate, and extracted with a saturated aqueous solution of sodium hydrogen carbonate. After washing this with ethyl acetate, ethyl acetate was added again, and the pH was adjusted to 1 with 0.5N hydrochloric acid. This was extracted with ethyl acetate under salting out, dried and concentrated to give the desired product as a pale yellow oil (121mg).
(Yield 70.5%) was obtained. IR value; ν CHCl3 nax cm -1 3320 (broad), 1740, 1610 PMR value; δ CDCl3 ppm 1.80 (3H, s), 2.23 to 3.15 (2H, complex m), 4.23 to 4.55 (1H, m), 5.02 (2H, s), 5.23 (2H, s), 7.52 (2H, d, J=9Hz), 8.19 (2H,
d, J=9Hz) (e) (4R)3(Z)-[1-methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-4-[3-(p-nitrobenzyl)oxycarbonyl- 2-oxopropyl]-azetidine-
Manufacture of 2-one 121 mg of the carboxylic acid obtained in Example 12(d) was dissolved in 3.0 ml of anhydrous tetrahydrofuran, 59.2 mg of N,N'-carbonylimidazole was added under a nitrogen atmosphere, and the mixture was stirred at room temperature for 2 hours. Separately, 113.6 mg of mono-p-nitrobenzyl malonic acid ester was dissolved in 2 ml of anhydrous tetrahydrofuran, and 46.7 mg of magnesium methoxide was added while stirring under a nitrogen atmosphere, followed by stirring at room temperature for 1 hour. The solvent was distilled off from the reaction solution under reduced pressure, and the previously synthesized imidazolide solution was added to this residue, followed by stirring at room temperature for 17.5 hours. The reaction solution was concentrated, the residue was dissolved in a mixture of ethyl acetate and 0.3N hydrochloric acid, the organic layer was separated, and the aqueous layer was further extracted with ethyl acetate. The organic layers were combined, washed with a saturated aqueous solution of sodium bicarbonate, then dried and concentrated to give a yellow oil. When this was purified by silica gel column chromatography [solvent: chloroform-methanol (6:1)], 115 mg of the desired product was obtained as a colorless oil (yield 63.9%).
was gotten. IR value; ν CHCl3 nax cm -1 1760, 1610 PMR value; δ CDCl3 ppm 1.75 (3H, s), 2.79 (1H, dd, J=
8Hz, 10Hz), 3.20 (1H, dd, J=
18Hz, 3Hz), 3.60 (2H, s), 4.22
(1H, dd, J = 10Hz, 3Hz), 5.02 (2H,
s), 5.24 (4H, s), 6.85 (1H, s), 7.47
(2H, d, J = 9Hz), 7.50 (2H, d, J
=9Hz), 8.18 (4H, d, J = 9Hz) (f) (4R)3(Z)-[1-methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-4-[3-( p-nitrobenzyl)oxycarbonyl-2-oxo-3-diazopropyl]-
Production of azetidin-2-one β-ketoester 115 obtained in Example 12(e)
mg and 0.039 ml of p-toluenesulfonyl azide were dissolved in 3.9 ml of acetanilyl, and 0.086 ml of triethylamine was added while stirring at 0°C.
Stirred for 20 minutes. The pale yellow oil obtained by concentrating the reaction solution was subjected to silica gel column chromatography [solvent: chloroform-methanol (15:1)]
When purified, 114 mg of the target product was obtained as a colorless oil.
(Yield 94.6%) was obtained. IR value; ν CHCl3 nax cm -1 2140, 1760, 1720 PMR value; δ CDCl3 ppm 1.79 (3H, s), 2.97 (1H, dd, J=
18Hz, 9Hz), 3.52 (1H, dd, J=
18Hz, 3Hz), 4.42 (1H, dd, J=9Hz,
3Hz), 5.02 (2H, s), 5.23 (2H, s),
5.36 (2H, s), 6.89 (1H, s), 7.52 (4H, d, J=9Hz), 8.18 (4H,
d, J=9Hz) (g) (5R)p-nitrobenzyl 6(z)-[1-methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-1-azabicyclo[3.2.0]hepta- Production of 3,7-dione-2-carboxylate 114 mg of the diazo compound obtained in Example 12(f) and 5.15 ml of anhydrous benzene degassed into 0.171 mg of rhodium acetate.
was added and heated under a nitrogen atmosphere at a bath temperature of 78°C for 1 hour and 20 minutes. After cooling, the insoluble matter was removed and the liquid was concentrated to obtain 114 mg (quantitative) of the target product as a pale yellow oil. IR value; ν CHCl3 nax cm -1 1760, 1610 PMR value; δ CDCl3 ppm 1.82 (3H, s), 2.43 (1H, dd, J=
18Hz, 6Hz), 2.90 (1H, dd, J=
18Hz, 6Hz), 4.59 (1H, t, J=
6Hz), 4.71 (1H, s), 5.00 (2H, s),
5.22 (4H, s), 7.48 (4H, d, J=
9Hz), 8.15 (4H, d, J = 9Hz) Example 13 (5R) p-nitrobenzyl 6 (z and E) - [1
-Methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-3-(2-pyrimidinylthio)-1-azabicyclo[3.2.0]hept-
Production of 2-en-7-one-2-carboxylate 114 mg of the bicycloketone obtained in Example 12 was dissolved in 4.2 ml of acetonitrile, cooled to 0°C, and 0.041 ml of diisopropylethylamine and 2.8 mg of 4-dimethylaminopyridine were added with stirring, followed by 0.046 mg of diphenyl chloride phosphate. ml of acetonitrile dissolved in 1 ml of acetonitrile, cooled to 0°C and added,
Stir for a minute. The reaction solution was cooled to -25°C, 0.177 ml of diisopropylethylamine was added, and then 49.5 mg of 2-mercaptopyrimidine was added immediately.
Stirred at ℃ for 30 minutes and stored in refrigerator for 13 hours. After adding ethyl acetate to the reaction solution, the mixture was washed with saturated brine, dried, and concentrated to obtain a brown oil. This was subjected to silica gel column chromatography [solvent: chloroform-methanol (30:
1)] and further separated by silica gel column chromatography [solvent: n-hexane-ethyl acetate (1:3)] to give 5.8 mg of Z form (yield 4.3%) and E form as a colorless oil. 22mg (yield
16.5%) was obtained. Z-form Specific rotation: [α] 23 D −79.0° (c0.29, THF) IR value: ν CHCl3 nax cm -1 3280 (broad), 1760, 1610 PMR value: δ CDCl3 ppm 1.85 (3H, s) , 3.18 (1H, dd, J=
18Hz, 9Hz), 3.92 (1H, dd, J=
18Hz, 10Hz), 4.82 (1H, m), 5.04 (2H, s), 5.25 (2H, s), 5.27 (1H, d, J = 14Hz), 5.53 (1H,
d, J = 14Hz), 7.05 (1H, t, J =
5Hz), 7.50 (2H, d, J=9Hz), 7.62 (2H,
d, J = 9Hz), 8.19 (4H, d, J =
9Hz), 8.55 (2H, d, J = 5Hz) E-form Specific rotation; [α] 23 D −27.0° (c1, THF) IR value; ν CHCl3 nax cm -1 1770, 1720 (shoulder), 1610 PMR Value; δ CDCl3 ppm 2.10 (3H, s), 3.18 (1H, dd, J=
18Hz, 9Hz), 3.82 (1H, dd, J=
18Hz, 10Hz), 4.70 (2H, s), 4.70~4.90 (1H, m), 5.22 (2H, s), 5.26 (1H, d, J=
14Hz), 5.52 (1H, d, J = 14Hz), 7.02 (1H,
t, J = 5Hz), 7.45 (2H, d, J =
9Hz), 7.62 (2H, d, J = 9Hz), 8.18 (4H,
d, J = 9Hz), 8.45 (2H, d, J =
5Hz) Example 14 (5R)6(z)-(1-methyl-2-hydroxyethylidene)-3-(2-pyrimidinylthio)-1
-Azabicyclo[3.2.0]hept-2-ene-7
Production of -one-2-carboxylic acid 5.4 mg of p-nitrobenzyl ester obtained in Example 13 was dissolved in a mixture of 0.5 ml of dioxane and 0.3 ml of 0.1 M phosphate buffer at pH 7.0, 8 mg of 5% palladium-carbon was added, and hydrogen (1 The mixture was stirred at room temperature for 2 hours under an atmosphere (atmospheric pressure). After the reaction, remove the catalyst,
When the solution is washed with ethyl acetate, an aqueous solution of the target substance is obtained.
3.0 ml was obtained. UV value; λ PBS nax (PH7.0) nm 242 Example 15 (5R)6(E)-(1-methyl-2-hydroxyethylidene)-3-(2-pyrimidinylthio)-1
-Azabicyclo[3.2.0]hept-2-ene-7
Production of -one-2-carboxylic acid 82.7 mg of p-nitrobenzyl ester obtained in Example 13 was dissolved in a mixture of 3.5 ml of dioxane and 3.5 ml of phosphate buffer of pH 7.0, and 5% palladium on carbon was added.
83 mg was added, and the mixture was stirred for 2 hours under a hydrogen (1 atm) atmosphere. This was treated and purified in the same manner as in Example 7 to obtain 25.3 mg (yield: 60.7%) of the desired product as a colorless powder. Specific optical rotation; [α] 18 D −186.7° (c0.375, H 2 O) IR value; ν KBr nax cm -1 3430 (broad), 1740, 1610, 1560 UV value; λ H2O nax nm (ε) 239.5 (18200) PMR value; δ D2O ppm ( D2O is 4.80) 2.08 (3H, s), 3.08 (1H, dd, J=
18Hz, 9Hz), 3.45 (1H, dd, J=
18Hz, 10Hz), 4.29 (2H, s), 5.0 (1H, m), 7.42 (1H,
t, J = 5Hz), 8.70 (2H, d, J =
5Hz) Example 16 (5R)p-nitrobenzyl6(E)-[1-methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-1-azabicyclo[3.2.0]hepta-3,7- Production of dione-2-carboxylate (a) 4(R)1-(t-butyldimethylsilyl)-
3(E)-[1-methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-4-
(2-t-butyldimethylsilyloxyethyl)-
Production of azetidin-2-one 309 mg of E-alcohol obtained in Example 12(a)
was dissolved in 5 ml of methylene chloride and added to 0.0 mL under nitrogen atmosphere.
142 mg of 4-dimethylaminopyridine after cooling to ℃.
Then, 250 mg of formic acid p-nitrobenzyl chloride dissolved in 2 ml of methylene chloride was added, and the mixture was stirred for 6 hours under ice cooling. When 3.5 hours and 5 hours had elapsed, the same amounts of 4-dimethylaminopyridine and a methylene chloride solution of formic acid p-nitrobenzyl chloride as above were added. Methylene chloride was added to the reaction solution, washed with water, dried, and concentrated to obtain 1.0 g of a yellow oil. This was purified by silica gel column chromatography [solvent: ethyl acetate-n-hexane (2:5)] to obtain 390 mg (yield: 87.2%) of the desired product as a yellow oil. IR value; ν CHCl3 nax cm -1 1750, 1735, 1610, 1530 PMR value; δ CDCl3 ppm 0.03 (6H, s), 0.22 (3H, s), 0.25 (3H, s), 0.84 (9H, s), 0.98 (9H, s), 1.81~2.13 (2H, m), 2.05 (3H, s), 3.68 (2H, t, J=
6Hz), 4.32 (1H, t, J=4Hz), 4.62 (2H,
s), 5.24 (2H, s), 7.50 (2H, d, J=
9Hz), 8.19 (2H, d, J = 9Hz) (b) (4R)3(E)-[1-methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-4-(2-hydroxyethyl )-Production of azetidin-2-one 390 mg of the disilyl compound obtained in Example 16(a) was
Dissolve in 90% methanol water and add 0.24 ml of concentrated hydrochloric acid under ice cooling.
was added dropwise, and the mixture was stirred for 2 hours under ice-cooling and then for 15 hours under water-cooling. A saturated aqueous sodium bicarbonate solution was added to the reaction mixture to adjust the pH to 7, and the mixture was concentrated.The residue was dissolved in ethyl acetate, dried, and concentrated. The residue was subjected to silica gel column chromatography [solvent;
When purified with chloroform-methanol (7:1), 220 mg of the desired product was obtained as colorless crystals (yield 93.2%).
was gotten. IR value; ν KBr nax cm -1 3400 (broad), 1750, 1710, 1610, 1540 PMR value; δ CDCl 3 −CD 3 OD (6:1) ppm 1.59-2.21 (2H, m), 2.05 (3H, s), 3.68 (2H, t, J=6Hz), 4.05 (2H,
s), 4.26 (1H, dd, J=9Hz, 4Hz), 4.63
(2H, s), 5.25 (2H, s), 7.52 (2H,
d, J = 9Hz), 8.20 (2H, d, J =
9Hz) (c) (4R)3(E)-[1-methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-4-carboxymethyl-azetidine-2-
on manufacturing 220 mg of the alcohol obtained in Example 16(b) was dissolved in 3 ml of pyridine, and 490 mg of chromic anhydride was added thereto.
Add the solution dissolved in 6 ml of pyridine and stir at room temperature.
Stirred for 14.5 hours. 10 ml of water was added to the reaction solution, extracted with ethyl acetate, and the extract was dried and concentrated to obtain 276 mg of the crude target product as a brown oil. IR value; ν Film nax cm -1 3240, 1750, 1600, 1520 (d) (4R)3(E)-[1-methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-4-[3 -(p-nitrobenzyl)oxycarbonyl-2-oxopropyl]-azetidine-
Manufacture of 2-one 276 mg of the crude carboxylic acid obtained in Example 12(c) was dissolved in 4.8 ml of anhydrous tetrahydrofuran, 112 mg of N,N'-carbonyldiimidazole was added at room temperature under a nitrogen atmosphere, and the mixture was stirred at room temperature for 2 hours. Separately, 245 mg of malonic acid mono p-nitrobenzyl ester was dissolved in 3.8 ml of anhydrous tetrahydrofuran, and 88.3 mg of magnesium methoxide was dissolved in 3.8 ml of anhydrous tetrahydrofuran.
was added and stirred at room temperature for 1 hour. Concentrate this and
The above imidazolide solution was added to this residue, and the mixture was stirred at room temperature for 12 hours. The reaction solution was concentrated, a mixture of ethyl acetate and 0.3N hydrochloric acid was added to the residue, and the mixture was extracted with ethyl acetate. The extract was washed with a saturated aqueous sodium bicarbonate solution and then dried to obtain a brown oil. This was subjected to silica gel column chromatography [solvent: chloroform-methanol (10:
1)], 175mg of the target product is obtained as colorless crystals.
(Yield: 51.5% compared to (c) above) was obtained. IR value; ν Film nax cm -1 3360 (broad), 1740 PMR value; δ CDCl3 ppm 2.10 (3H, s), 2.83 (1H, dd, J=
18Hz, 9Hz), 3.32 (1H, dd, J=
18Hz, 2Hz), 3.50 (2H, s), 4.40 (1H, m), 4.55 (1H, s), 4.63 (1H, s), 5.22 (4H, s), 6.50 (1H, s), 7.47 (4H ,d,J=
9Hz), 8.15 (4H, d, J = 9Hz) (e) (4R)3(E)-[1-methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-4-[3-(p -Nitrobenzyl)oxycarbonyl-2-oxo-3-diazopropyl]-
Production of azetidin-2-one β-ketoester 175 obtained in Example 16(d)
mg was dissolved in 5.8 ml of acetonitrile, 0.058 ml of p-toluenesulfonyl azide and 0.130 ml of triethylamine were added under ice cooling, and the mixture was stirred at room temperature for 130 minutes. The reaction solution was concentrated, and the residue was purified by silica gel column chromatography [solvent: ethyl acetate-n-hexane (1:1)] to obtain 176 mg (yield 96.0%) of the desired product as a yellow oil. IR value; ν Film nax cm -1 3160 (broad), 2130, 1740, 1645, 1605, 1520 PMR value; δ CDCl3 ppm 2.04 (3H, s), 3.02 (1H, dd, J=
18Hz, 9Hz), 3.58 (1H, dd, J=
18Hz, 3Hz), 4.48 (1H, m), 4.62
(2H, s), 5.22 (2H, s), 5.30 (2H, s), 6.68 (1H, broad s), 7.47 (4H, d,
J = 9Hz), 8.16 (4H, d, J = 9Hz) (f) (5R) p-nitrobenzyl 6(E)-[1-methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-1 -Production of azabicyclo[3.2.0]hepta-3,7-dione-2-carboxylate 176 mg of the diazo compound obtained in Example 16(e) was dissolved in 9.5 ml of degassed anhydrous benzene, and 0.3 mg of rhodium acetate was dissolved in 9.5 ml of degassed anhydrous benzene.
mg was added thereto, and the mixture was stirred for 90 minutes at a bath temperature of 78°C under a nitrogen atmosphere. The reaction solution was filtered and concentrated to obtain 165 mg (yield 98.6%) of the desired product as a yellow oil. IR value; ν Film nax cm -1 1750, 1605, 1520 PMR value; δ CDCl3 ppm 2.08 (3H, s), 2.44 (1H, dd, J=
18Hz, 7Hz), 2.82 (1H, dd, J=
18Hz, 7Hz), 4.62 (1H, t, J=
7Hz), 4.70 (2H, s), 4.74 (1H, s),
5.24 (4H, s), 7.50 (4H, d, J=9Hz), 8.18 (4H,
d, J=9Hz) Example 17 (5R)p-nitrobenzyl 6(z and E)-[1
-Methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-3-(2-pyrrolimidinylthio)-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylate Manufacturing of 74.0 mg of the bicycloketone obtained in Example 16 was mixed with 5.36 ml of acetonitrile and dimethylformamide.
Dissolve in 0.4 ml of the mixed solution, add 0.028 ml of diisopropylethylamine under ice cooling under a nitrogen atmosphere, then add a solution of 0.031 ml of diphenyl chloride phosphoric acid dissolved in 0.1 ml of acetonitrile after cooling to 0°C, and add under ice cooling. The mixture was stirred for 10 minutes. The reaction solution was cooled to -25°C, 0.102 ml of diisopropylethylamine and 16.9 mg of 2-mercaptopyrimidine were added, and the mixture was heated to 0°C.
After stirring for 30 minutes, the mixture was left in the refrigerator for 17 hours. Ethyl acetate was added to the reaction solution, washed with saturated brine, dried and concentrated. The residue was purified by silica gel column chromatography [solvent: chloroform-methanol (30:1)], and then further separated by silica gel column chromatography [solvent: ethyl acetate-n-hexane (3:1)]. 38.9 mg (yield: 44.8%) of the desired E-isomer and 10.4 mg (yield: 14.2%) of the Z-isomer were obtained as a yellow oil. The physicochemical properties of all of these were consistent with the compound obtained in Example 13. Example 18 (5R)p-nitrobenzyl 6(E and z)-[1
-Methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-3-[2-(p-nitrobenzyloxycarbonyl)aminoethylthio]-1-azabicyclo[3.2.0]hept-2-ene-7 -Production of -one-2-carboxylate 138 mg of the bicycloketone obtained in Example 16 was mixed with 10 ml of acetonitrile and 0.5 dimethylformamide.
ml of the mixed solution, cooled to 0° C. and stirred under a nitrogen atmosphere. Diisopropylethylamine
After adding 38 mg and stirring for 1 minute, a solution of 75.65 mg of diphenyl chloride phosphate dissolved in 1.83 ml of acetonitrile was added after cooling to 0°C, and the mixture was stirred for 10 minutes.
The reaction solution was cooled to -25°C, 140mg of diisopropylethylamine was added, and immediately 72.09mg of N-p-nitrobenzyloxycarbonylcysteamine dissolved in 4.6ml of acetonitrile was added, and the mixture was heated at 0°C for 30 minutes.
After stirring for a minute, the mixture was left in the refrigerator for 15 hours.
Ethyl acetate was added to the reaction solution, which was then washed with water, dried, and concentrated to obtain 300 mg of a brown oil. This was applied to a silica gel column and chloroform-
Elution with methanol (20:1) followed by separation with n-hexane-ethyl acetate (2:1) yielded 58 mg of the desired (E) compound as a yellow oil (yield 29.2%).
and 27 mg (yield 13.6%) of the (Z) isomer were obtained. (E) Body Specific rotation: [α] 22 D +20.0° (c2.9, THF) IR value: ν CHCl3 nax cm -1 1755, 1715, 1520 UV value: λ THF nax nm (ε) 249 ( 24100), 262 (34600) PMR value; δ CDCl3 ppm 2.07 (3H, s), 2.8 to 3.6 (6H, complex m) 4.6 to 4.96 (3H, complex m) 5.0 to 5.65 (7H, complex m) 7.42 (2H, d, J = 8Hz), 7.51 (2H,
d, J = 8Hz), 7.63 (2H, d, J =
8Hz), 8.15 (2H, d, J = 8Hz), 8.17 (2H,
d, J = 8Hz), 8.20 (2H, d, J =
8Hz) (Z) body Specific rotation: [α] 22 D −16.3° (c1.35, THF) IR value: ν CHCl3 nax cm -1 1760, 1750 (shoulder) 1715, 1520 PMR value: δ CDCl3 ppm 1.86 (3H, s), 2.70-3.60 (6H, complex m), 4.72 (1H, dd, J=8Hz,
10Hz), 5.04 (2H, broads), 5.08~
5.60 (6H, complex m), 7.25
(2H, d, J = 8Hz), 7.32 (2H, d, J
= 8Hz), 7.42 (2H, d, J = 8Hz),
8.04-8.35 (6H, complex m) Example 19 (5R) p-nitrobenzyl 6(E and z)-[1
-Methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-3-ethylthio-
1-azabicyclo[3.2.0]hept-2-ene-
Preparation of 7-one-2-carboxylate Example 18 was prepared using 152 mg of the bicycloketone obtained in Example 16 and 19.26 mg of ethyl mercaptan.
silica gel chromatography using n-hexane-ethyl acetate (1:1), followed by chloroform-methanol (50:1).
separated by silica gel chromatography using
After purification, the desired (E) form 48 mg (yield 29.2%)
and 7 mg (yield 4.3%) of the (Z) isomer were each obtained as a yellow oil. (E) Body IR value: ν CHCl3 nax cm -1 1765, 1730 (shoulder), 1525 PMR value: δ CDCl3 ppm 1.18 (3H, t, J=6Hz), 2.07 (3H,
s), 3.05-3.90 (4H, complex m), 4.50-4.90 (3H, complex m), 5.19 (1H, d, J = 14Hz), 5.20 (2H,
s), 5.41 (1H, d, J = 14Hz), 7.45
(2H, d, J = 8Hz), 7.54 (2H, d, J
= 14Hz), 8.12 (2H, d, J = 8Hz), 8.14 (2H, d, J = 8Hz) (Z) body PMR value: δ CDCl3 ppm 1.19 (3H, t, J = 6Hz), 1.85 (3H,
s), 3.0-3.8 (4H, complex m), 4.5-4.9 (1H, m), 5.04 (2H, broad s), 5.20 (1H, d, J=14Hz), 5.24 (2H,
s), 5.50 (1H, d, J = 14Hz), 7.52
(2H, d, J = 8Hz), 7.63 (2H, d, J
= 8Hz), 8.17 (2H, d, J = 8Hz), 8.20 (2H, d, J = 8Hz) Example 20 (5R) p-Nitrobenzyl 6 (E and z) - [1
-Methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-3-(2-pyridylthio)-1-azabicyclo[3.2.0]hept-2-
Production of en-7-one-2-carboxylate Example 18 using 142 mg of the bicycloketone obtained in Example 16 and 32.2 mg of 2-mercaptopyridine.
After reaction treatment in the same manner as above and separation and purification using silica gel column chromatography [solvent: n-hexane-ethyl acetate (2:5)], the desired (E) form was obtained.
73.6 mg (yield 44.2%) and 5.1 mg (yield
3.1%) were obtained in each case as a yellow oil. (E) Body Specific rotation: [α] 22.5 D −30° (c1, THF) IR value: ν CHCl3 nax cm -1 2940, 1760, 1710, 1610, 1560 UV value: λ THF nax nm (ε) 285 (15600), 262 (23900) PMR value: δ CDCl3 ppm 2.08 (3H, s), 3.03 (1H, dd, J=
18Hz, 8Hz), 3.33 (1H, dd, J=
18Hz, 10Hz), 4.68 (2H, broad s), 4.84 (1H, m), 5.19 (2H, s), 5.28
(1H, d, J = 14Hz), 5.56 (1H, d,
J=14Hz), 7.20 (1H, m), 7.36-7.64
(4H, complex m), 7.69 (2H,
d, J = 8Hz), 8.24 (4H, d, J =
8Hz), 8.49 (1H, dd, J=5Hz, 2Hz) (Z) body IR value: ν CHCl3 nax cm -1 2910, 1750, 1605, 1570, 1560 PMR value: δ CDCl3 ppm (main peak) 1.79 (3H , s), 5.06 (2H, s), 5.25
(1H, d, J=14Hz), 5.28 (2H, s), 5.43 (1H, d, J=14Hz), 7.0~7.3
(1H, m), 7.4-7.8 (6H, complex m), 8.24 (4H, d, J = 8Hz), 8.48
(1H, m) Example 21 (5R) p-nitrobenzyl 6(E and z)-[1
-Methyl-2-(p-nitrobenzyl)oxycarbonyloxyethylidene]-3-(4,6-dimethyl-2-pyrimidinylthio)-1-azabicyclo[3.2.0]hept-2-en-7-one- 2-
Production of carboxylates 119 mg of bicycloketone and 4,6-dimethyl-2-mercaptopyrimidine obtained in Example 16
Using 34 mg, reaction treatment was carried out in the same manner as in Example 18, and n-
Separation and purification by silica gel chromatography using hexane-ethyl acetate (1:2) and then chloroform-methanol (20:1) as solvents yielded 60 mg (yield 41.2%) of the desired (E) form and 10 mg of the (Z) form. (yield 6.9%) were obtained as pale yellow powders. (E) Body IR value: ν CHCl3 nax cm -1 1760, 1715 (shoulder), 1560, 1525 PMR value: δ CDCl3 ppm 2.10 (3H, s), 2.35 (6H, s), 3.20
(1H, dd, J = 18Hz, 10Hz), 3.86
(1H, dd, J = 18Hz, 10Hz), 4.70
(2H, broad s), 4.87 (1H, dd, J
= 10Hz, 8Hz), 5.22 (2H, s), 5.26 (1H, d, J = 14Hz), 5.50 (1H,
d, J=14Hz), 6.73 (1H, s), 7.45
(2H, d, J = 8Hz), 7.64 (2H, d, J
= 8Hz), 8.14 (2H, d, J = 8Hz),
8.18 (2H, d, J = 8Hz) (Z) body IR value: ν CHCl3 nax cm -1 1765, 1715 (shoulder), 1590, 1530 PMR value: δ CDCl3 ppm 1.85 (3H, s), 2.41 (6H, s), 3.15
(1H, dd, J = 18Hz, 8Hz), 3.92 (1H,
dd, J=18Hz, 10Hz), 4.82 (1H, dd, J=10Hz, 8Hz), 5.06
(2H, s), 5.24 (1H, d, J = 14Hz), 5.26 (2H, s), 5.52 (1H, d, J =
14Hz), 6.80 (1H, s), 7.53 (2H, d, J=
8Hz), 7.65 (2H, d, J = 8Hz), 8.20 (4H, broad d, J = 8Hz) Example 22 (5R)6(E)-(1-methyl-2-hydroxyethylidene)-3-( Production of 2-pyridylthio)-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid 57 mg of p-nitrobenzyl ester [(E) form] obtained in Example 20 was mixed with 2.4 ml of dioxane and pH 7.0.
The mixture was dissolved in a mixture of 1.4 ml of phosphate buffer, 57 mg of 5% palladium on carbon was added, and the mixture was stirred for 2 hours under a hydrogen atmosphere (1 atm). When this was treated and purified in the same manner as in Example 7, 5.7 mg of the target product was obtained as a pale yellow powder (yield:
19.9%) was obtained. Specific optical rotation: [α] 25 D −115° (c0.3, water) IR value: ν KBr nax cm -1 1760, 1730, 1600, 1575 UV value: λ PBS nax (PH7.0) nm (ε) 290.5 (6620), 238 (14100) PMR value: δ D2O ppm (with heavy water as 4.80) 2.11 (3H, s), 2.98 (2H, d, J=
10Hz), 4.28 (2H, s), 5.10 (1H, m), 7.56
(1H, dd, J = 6Hz, 4Hz), 7.76 (1H,
d, J = 8Hz), 7.89 (1H, m), 8.62 (1H, broad s, J = 4Hz) Example 23 (5R)6(E)-(1-methyl-2-hydroxyethylidene)-3-( Production of 4,6-dimethyl-2-pyrimidylthio)-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid 60 mg of p-nitrobenzyl ester [(E) form] obtained in Example 21 was mixed with 2.54 ml of dioxane and pH 7.0.
The mixture was dissolved in a mixture of 1.6 ml of phosphate buffer, 60 mg of 5% palladium on carbon was added, and the mixture was stirred for 2 hours under a hydrogen atmosphere (1 atm). This was treated and purified in the same manner as in Example 7 to obtain 24.7 mg (yield 78.5%) of the target product as a pale yellow powder. Specific optical rotation: [α] 29 D −145.2° (c0.785, water) IR value: ν KBr nax cm -1 1745, 1620 (shoulder), 1590 UV value: λ PBS nax (PH7.0) nm (ε ) 282 (6850), 239 (13470) PMR value: δ D2O ppm (with heavy water as 4.80) 2.08 (3H, s), 2.51 (6H, s), 2.98
(1H, dd, J = 17Hz, 9Hz), 3.48 (1H,
dd, J = 17Hz, 10Hz), 4.30 (2H,
s), 5.06 (1H, dd, J=10Hz, 9Hz),
7.16 (1H, s).

Claims (1)

【特許請求の範囲】 1 一般式 (式中、R1及びR2は同一又は異なつて、メチ
ル基又はヒドロキシメチル基を、R3はピリジル
基又は低級アルキル基で置換されていてもよいピ
リミジニル基を、R4は水素原子又は置換基を有
していてもよいベンジル基を示す)で表わされる
化合物及びその塩。
[Claims] 1. General formula (In the formula, R 1 and R 2 are the same or different and represent a methyl group or a hydroxymethyl group, R 3 is a pyridyl group or a pyrimidinyl group optionally substituted with a lower alkyl group, and R 4 is a hydrogen atom or a substituted A compound represented by (representing a benzyl group which may have a benzyl group) and a salt thereof.
JP57047829A 1982-03-25 1982-03-25 Novel beta-lactam type compound and preparation thereof Granted JPS58164591A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP57047829A JPS58164591A (en) 1982-03-25 1982-03-25 Novel beta-lactam type compound and preparation thereof
US06/477,369 US4511509A (en) 1982-03-25 1983-03-21 3-Alkylidine azetidine compound and their production
EP83301648A EP0091239A1 (en) 1982-03-25 1983-03-24 Azetidine derivatives and a process for their production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57047829A JPS58164591A (en) 1982-03-25 1982-03-25 Novel beta-lactam type compound and preparation thereof

Publications (2)

Publication Number Publication Date
JPS58164591A JPS58164591A (en) 1983-09-29
JPH0314035B2 true JPH0314035B2 (en) 1991-02-25

Family

ID=12786239

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57047829A Granted JPS58164591A (en) 1982-03-25 1982-03-25 Novel beta-lactam type compound and preparation thereof

Country Status (1)

Country Link
JP (1) JPS58164591A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3169321D1 (en) * 1980-03-27 1985-04-25 Merck & Co Inc Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals
JPS5740485A (en) * 1980-08-25 1982-03-06 Shionogi & Co Ltd Novel antibiotic pa-39504-x3 and its preparation
JPS57176982A (en) * 1981-04-24 1982-10-30 Shionogi & Co Ltd Dioxolanylazetidinone compound, its preparation and use

Also Published As

Publication number Publication date
JPS58164591A (en) 1983-09-29

Similar Documents

Publication Publication Date Title
JPH0149718B2 (en)
JPH0248556B2 (en)
JPH0586023A (en) Beta lactam antibiotic intermediate
EP0078026B1 (en) Antibiotic synthesis
EP0041768A2 (en) Beta-lactam compounds, their preparation and use
JPH0557980B2 (en)
JPS60120885A (en) Manufacture of penems
US4639335A (en) Stereocontrolled acetoxyazetidinone process
JPH0314035B2 (en)
CN101172962B (en) Synthetic intermediate of carbapenem compound for oral administration
JPH066570B2 (en) Process for producing 4-acetoxy-3-hydroxyethylazetidin-2-one derivative
JPS58103358A (en) Synthesization of antibiotic
US4511509A (en) 3-Alkylidine azetidine compound and their production
DK161970B (en) azetidinone
EP0091576A2 (en) 7-Oxo-4-thia-1-azabicyclo(3,2,0)heptane derivatives
JPH0237360B2 (en)
JPS6034970A (en) 2-Heterocyclyl-lower alkyl-2-penem compound, its production method, and pharmaceutical preparations containing the compound
JPH0479333B2 (en)
EP0230792B1 (en) Process for making chiral 1 beta-methyl-carbapenem intermediates
JPH0371434B2 (en)
JP2620533B2 (en) New amino acid derivatives
JPS62289558A (en) Beta-lactam compound and production thereof
JP2003064087A (en) Crystals of azetidinone compounds
JPH0240670B2 (en)
JP2652047B2 (en) Method for producing 4-benzoyloxy-3-hydroxyethylazetidin-2-one derivative